| World Health Organization | 60.0 | 21 | 0 |
| Fertility and Sterility | 55.4 | 3 | 3 |
| Texas Fertility Center | 49.5 | 3 | 2 |
| Prelude Fertility | 49.5 | 3 | 2 |
| KINDERWUNSCHZENTRUM LOS ANGELES, INC. | 49.5 | 3 | 2 |
| Pacific Fertility Center Los Angeles (PFCLA) | 49.5 | 3 | 2 |
| Journal of Assisted Reproduction and Genetics | 43.9 | 2 | 2 |
| Reproductive Medicine and Biology | 43.9 | 2 | 2 |
| Pacific Fertility Center | 41.2 | 3 | 1 |
| The Effects of Total Motile Sperm Count on Spontaneous Pregnancy Rate and Pregnancy After IUI Treatment in Couples with Male Factor and Unexplained Infertility | 40.0 | 0 | 6 |
| Alterations in the sperm histone-retained epigenome are associated with unexplained male factor infertility and poor blastocyst development in donor oocyte IVF cycles | 40.0 | 0 | 6 |
| Oregon Health Authority | 37.8 | 6 | 0 |
| Information Retrieval | 37.8 | 6 | 0 |
| Inflammopharmacology | 37.8 | 6 | 0 |
| Complex Metals: An Open Access Journal | 37.8 | 6 | 0 |
| Facial plastic surgery & aesthetic medicine | 37.8 | 6 | 0 |
| Recent Progress in Pharmacological Therapy of Male Subfertility - a Review* | 36.8 | 0 | 5 |
| Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes | 36.8 | 0 | 5 |
| The Management of Uterine Fibroids in Women With Otherwise Unexplained Infertility | 36.8 | 0 | 5 |
| EXPRESSION OF CONCERN: Addition of growth hormone to the microflare stimulation protocol among women with poor ovarian response | 36.8 | 0 | 5 |
| Clinical outcomes and development of children born to couples with obstructive and nonobstructive azoospermia undergoing testicular sperm extraction-intracytoplasmic sperm injection: A comparative study | 36.8 | 0 | 5 |
| Comparison of pregnancy rates in pre-treatment male infertility and low total motile sperm count at insemination | 36.8 | 0 | 5 |
| Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles | 36.8 | 0 | 5 |
| The question of sperm DNA fragmentation testing in the male infertility work-up: a response to Professor Lewis' commentary | 36.8 | 0 | 5 |
| Vaginal Progesterone Versus Progesterone in Oil in Donor Egg Recipient In Vitro Fertilization Cycles Utilizing Vitrified Donor Eggs | 36.8 | 0 | 5 |
| Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART) | 36.8 | 0 | 5 |
| Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer | 36.8 | 0 | 5 |
| In Vitro Cellular & Developmental Biology - Animal | 35.6 | 2 | 1 |
| Fertility Center of San Antonio | 35.6 | 2 | 1 |
| Midwest Fertility Specialists | 35.6 | 2 | 1 |
| San Diego Fertility Center | 35.6 | 2 | 1 |
| Fertility Center of Las Vegas | 35.6 | 2 | 1 |
| Colorado Center for Reproductive Medicine | 35.6 | 2 | 1 |
| Shady Grove Fertility Center | 35.6 | 2 | 1 |
| Sher Fertility | 35.6 | 2 | 1 |
| New Hope Fertility Center | 35.6 | 2 | 1 |
| Pacific Centre for Reproductive Medicine | 35.6 | 2 | 1 |
| Merrion Fertility Clinic | 35.6 | 2 | 1 |
| Michigan Reproductive Medicine | 35.6 | 2 | 1 |
| Injectable and bioresorbable calcium phosphate delivery system with gentamicin sulphate for treatment of bone diseases: in vitro study | 35.6 | 2 | 1 |
| Effect of in vitro hydrolysis on the compressive behavior and strain rates dependence of tricalcium phosphate/poly(L-lactic acid) composites | 35.6 | 2 | 1 |
| Regional Studies, Regional Science | 34.8 | 5 | 0 |
| Territory, Politics, Governance | 34.8 | 5 | 0 |
| Journal of Environmental Economics and Policy | 34.8 | 5 | 0 |
| assisted reproductive technology | 33.1 | 0 | 4 |
| What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation? | 33.1 | 0 | 4 |
| Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination | 33.1 | 0 | 4 |
| Decline in sperm count and motility in young adult men from 2003 to 2013: observations from a U.S. sperm bank | 33.1 | 0 | 4 |
| Limitations of semen analysis as a test of male fertility and anticipated needs from newer tests | 33.1 | 0 | 4 |
| Effect of Sperm Count on Success of Intrauterine Insemination in Couples Diagnosed with Male Factor Infertility | 33.1 | 0 | 4 |
| Anti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone | 33.1 | 0 | 4 |
| Predictive value of sperm motility characteristics assessed by computer-assisted sperm analysis in intrauterine insemination with superovulation in couples with unexplained infertility | 33.1 | 0 | 4 |
| In vitro fertilization treatment for severe male factor: a comparative study of intracytoplasmic sperm injection with testicular sperm extraction and with spermatozoa from ejaculate | 33.1 | 0 | 4 |
| Is intracytoplasmic sperm injection necessary for couples undergoing in vitro fertilization-embryo transfer with normal semen analyses but failing hamster egg penetration assays? | 33.1 | 0 | 4 |
| Anti-mullerian hormone cut-off values for predicting poor ovarian response to exogenous ovarian stimulation in in-vitro fertilization | 33.1 | 0 | 4 |
| Comparing blastocyst quality and live birth rates of intravaginal culture using INVOcell™ to traditional in vitro incubation in a randomized open-label prospective controlled trial | 33.1 | 0 | 4 |
| The predictive value of anti-Mullerian hormone on embryo quality, blastocyst development, and pregnancy rate following in vitro fertilization-embryo transfer (IVF-ET). | 33.1 | 0 | 4 |
| Blastocyst culture and transfer in clinical-assisted reproduction | 33.1 | 0 | 4 |
| A prospective randomized study to evaluate the effect of hyaluronic acid sperm selection on the intracytoplasmic sperm injection outcome of patients with unexplained infertility having normal semen parameters | 33.1 | 0 | 4 |
| Blastocyst Transfer Ameliorates Live Birth Rate Compared with Cleavage-Stage Embryos Transfer in FreshIn VitroFertilization or Intracytoplasmic Sperm Injection Cycles: Reviews and Meta-Analysis | 33.1 | 0 | 4 |
| Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion | 33.1 | 0 | 4 |
| Blastocyst culture and transfer in clinical-assisted reproduction: a committee opinion | 33.1 | 0 | 4 |
| Sperm DNA damage caused by oxidative stress: modifiable clinical, lifestyle and nutritional factors in male infertility | 33.1 | 0 | 4 |
| Clinical rationale for cryopreservation of entire embryo cohorts in lieu of fresh transfer | 33.1 | 0 | 4 |
| Cytological evaluation of spermatogenesis: a novel and simple diagnostic method to assess spermatogenesis in non-obstructive azoospermia using testicular sperm extraction specimens | 33.1 | 0 | 4 |
| Effect of smoking on ovarian reserve and ovarian stimulation in in- vitro fertilization and embryo transfer | 33.1 | 0 | 4 |
| In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. | 33.1 | 0 | 4 |
| Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study | 33.1 | 0 | 4 |
| Association of uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination for unexplained infertility. | 33.1 | 0 | 4 |
| Predictive value of sperm morphology and progressively motile sperm count for pregnancy outcomes in intrauterine insemination | 33.1 | 0 | 4 |
| Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles | 33.1 | 0 | 4 |
| Impact of single embryo transfer policy on perinatal outcomes in fresh and frozen cycles—analysis of the Japanese Assisted Reproduction Technology registry between 2007 and 2012 | 33.1 | 0 | 4 |
| Total motile sperm count: a better indicator for the severity of male factor infertility than the WHO sperm classification system | 33.1 | 0 | 4 |
| Basal serum testosterone levels correlate with ovarian reserve and ovarian response in cycling women undergoing in vitro fertilization | 33.1 | 0 | 4 |
| Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials | 33.1 | 0 | 4 |
| The impact of spermatic vein ligation on the male factor in in vitro fertilization-embryo transfer and its relation to testosterone levels before and after operation | 33.1 | 0 | 4 |
| Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization | 33.1 | 0 | 4 |
| Are sperm DNA fragmentation, hyperactivation, and hyaluronan-binding ability predictive for fertilization and embryo development in in vitro fertilization and intracytoplasmic sperm injection? | 33.1 | 0 | 4 |
| Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: a randomized prospective study. | 33.1 | 0 | 4 |
| Embryo transfer by reproductive endocrinology fellows vs attending physicians: are live birth rates comparable? | 33.1 | 0 | 4 |
| Obstetrical and neonatal outcomes from the BEST Trial: single embryo transfer with aneuploidy screening improves outcomes after in vitro fertilization without compromising delivery rates | 33.1 | 0 | 4 |
| Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation | 33.1 | 0 | 4 |
| AB127. The value of diagnostic micro-dissection testicular sperm extraction before start of IVF cycles for couples with non-obstructive azoospermia male factor | 33.1 | 0 | 4 |
| Histological evaluation of endometrium on the day of oocyte retrieval after gonadotrophin-releasing hormone agonist-follicle stimulating hormone ovulation induction for in-vitro fertilization | 33.1 | 0 | 4 |
| Nondominant small follicles are a promising source of mature oocytes in modified natural cycle in vitro fertilization and embryo transfer | 33.1 | 0 | 4 |
| Live birth following in vitro maturation of oocytes retrieved from extracorporeal ovarian tissue aspiration and embryo cryopreservation for 5 years | 33.1 | 0 | 4 |
| Uncommon but devastating event: total fertilisation failure following intracytoplasmic sperm injection | 33.1 | 0 | 4 |
| Pregnancy rates in donor oocyte cycles compared to similar autologous in vitro fertilization cycles: an analysis of 26,457 fresh cycles from the Society for Assisted Reproductive Technology | 33.1 | 0 | 4 |
| Can intracytoplasmic sperm injection prevent total fertilization failure and enhance embryo quality in patients with non-male factor infertility? | 33.1 | 0 | 4 |
| Colour Doppler assessment of ascendent uterine artery perfusion in an in-vitro fertilization-embryo transfer programme after pituitary desensitization and ovarian stimulation with human recombinant follicle stimulating hormone | 33.1 | 0 | 4 |
| Prediction of ovarian reserve based on day-3 serum follicle stimulating hormone concentrations during the pituitary suppression cycle using a gonadotropin releasing hormone agonist in patients undergoing in vitro fertilization-embryo transfer | 33.1 | 0 | 4 |
| Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia: testicular histology can predict success of sperm retrieval | 33.1 | 0 | 4 |
| The effect of female age and ovarian reserve on pregnancy rate in male infertility: treatment of azoospermia with sperm retrieval and intracytoplasmic sperm injection | 33.1 | 0 | 4 |
| The role of in vitro fertilization and intracytoplasmic sperm injection in couples with unexplained infertility after failed intrauterine insemination | 33.1 | 0 | 4 |
| Mouse in vitro fertilization, embryo development and viability, and human sperm motility in substances used for human sperm preparation for assisted reproduction | 33.1 | 0 | 4 |
| Ovarian stimulation in women undergoing in-vitro fertilization and embryo transfer using recombinant human follicle stimulating hormone (Gonal-F) in non-down-regulated cycles | 33.1 | 0 | 4 |
| Efficacy and safety of Ding-Kun-Dan for female infertility patients with predicted poor ovarian response undergoing in vitro fertilization/intracytoplasmic sperm injection: study protocol for a randomized controlled trial | 33.1 | 0 | 4 |
| Single embryo implantation per IVF cycle: the answer to every request for assisted reproduction? | 33.1 | 0 | 4 |
| Family Building by Same-Sex Male Couples via Gestational Surrogacy | 33.1 | 0 | 4 |
| The effect of intracytoplasmic sperm injection and semen parameters on blastocyst development in vitro | 33.1 | 0 | 4 |
| Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ∼15,000 women | 33.1 | 0 | 4 |
| How much does the uterus matter? perinatal outcomes are improved when donor oocyte embryos are transferred to gestational carriers compared to intended parent recipients: an analysis of the 2014 SART data | 33.1 | 0 | 4 |
| Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous Cycle | 33.1 | 0 | 4 |
| A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment | 33.1 | 0 | 4 |
| Anti-Mullerian Hormone (AMH) Versus Antral Follicle Count (AFC) Guided rFSH Dosing Study | 33.1 | 0 | 4 |
| Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization | 33.1 | 0 | 4 |
| Acupuncture for Treatment of Patients With Poor Ovarian Response | 33.1 | 0 | 4 |
| Effect of Treatment With Corifollitropin Alpha in Vitro Fertilization in Patients With Poor Ovarian Response. | 33.1 | 0 | 4 |
| Gamete intra-Fallopian transfer or in-vitro fertilization after failed ovarian stimulation and intrauterine insemination in unexplained infertility? | 33.1 | 0 | 4 |
| The results of in vitro fertilization-embryo transfer in couples with unexplained infertility failing to conceive with superovulation and intrauterine insemination | 33.1 | 0 | 4 |
| Comparable clinical outcomes of tubal embryo transfer for oligoastheno-teratozoospermia treated with intracytoplasmic sperm injection and for female infertility treated with in vitro fertilization | 33.1 | 0 | 4 |
| First established pregnancy and birth after induction of ovulation with recombinant human follicle stimulating hormone during in vitro fertilization-embryo transfer and intracytoplasmic sperm injection | 33.1 | 0 | 4 |
| Sperm motility in the semen analysis affects the outcome of superovulation intrauterine insemination in the treatment of infertile Asian couples with male factor infertility | 33.1 | 0 | 4 |
| Ovarian tissue and oocyte cryopreservation | 33.1 | 0 | 4 |
| Blastocyst culture and transfer in clinical-assisted reproduction | 33.1 | 0 | 4 |
| Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women of more advanced reproductive age with elevated serum follicle stimulating hormone (FSH) levels | 33.1 | 0 | 4 |
| In vitro fertilization laboratory. Clinical features of assisted reproduction techniques. Male infertility treatment in a reproduction medicine centre | 33.1 | 0 | 4 |
| Ovarian tissue and oocyte cryopreservation | 33.1 | 0 | 4 |
| Outcomes of in vitro fertilization-embryo transfer and intracytoplasmic sperm injection for non-male infertility patients with a low number of oocytes retrieved | 33.1 | 0 | 4 |
| Prediction of ovarian reserve, poor response and pregnancy outcome based on basal antral follicle count and age in patients undergoing in vitro fertilization-embryo transfer | 33.1 | 0 | 4 |
| Monozygotic twinning after in vitro fertilization/intracytoplasmic sperm injection treatment is not related to advanced maternal age, intracytoplasmic sperm injection, assisted hatching, or blastocyst transfer | 33.1 | 0 | 4 |
| Fertility preservation in breast cancer patients by embryo cryopreservation after ovarian stimulation with letrozole and FSH | 33.1 | 0 | 4 |
| Re: Relationship between Testicular Sperm Extraction and Varicocelectomy in Patients with Varicocele and Nonobstructive Azoospermia | 33.1 | 0 | 4 |
| Effect of insemination timing on pregnancy outcome in association with female age, sperm motility, sperm morphology and sperm concentration in intrauterine insemination | 33.1 | 0 | 4 |
| Current Preventive Strategies for Preovulatory Progesterone Elevation During Ovarian Stimulation for In Vitro Fertilization | 33.1 | 0 | 4 |
| Live birth rate comparison of three controlled ovarian stimulation protocols for in vitro fertilization-embryo transfer in patients with diminished ovarian reserve after endometrioma cystectomy: a retrospective study | 33.1 | 0 | 4 |
| Blastocyst culture and transfer in clinically assisted reproduction: a committee opinion | 33.1 | 0 | 4 |
| Performance of preimplantation genetic testing for aneuploidy in IVF cycles for patients with advanced maternal age, repeat implantation failure, and idiopathic recurrent miscarriage | 33.1 | 0 | 4 |
| Association between testosterone, semen parameters, and live birth in men with unexplained infertility in an intrauterine insemination population | 33.1 | 0 | 4 |
| Intrauterine insemination performance characteristics and post-processing total motile sperm count in relation to live birth for couples with unexplained infertility in a randomised, multicentre clinical trial | 33.1 | 0 | 4 |
| Intracytoplasmic sperm injection (ICSI) for non-male factor indications: a committee opinion | 33.1 | 0 | 4 |
| Medroxyprogesterone acetate used in ovarian stimulation is associated with reduced mature oocyte retrieval and blastocyst development: a matched cohort study of 825 freeze-all IVF cycles | 33.1 | 0 | 4 |
| [Impact of sperm DNA fragmentation on the outcome of frozen-thawed blastocyst transfer in in vitro fertilization and embryo transfer] | 33.1 | 0 | 4 |
| Sperm DNA fragmentation reduces embryo development and ongoing pregnancy in couples with non-male factor infertility undergoing intracytoplasmic sperm injection cycles | 33.1 | 0 | 4 |
| Anti-mullerian hormone level as a predictor of ovarian reserve in patients seeking fertility preservation versus infertility treatment | 33.1 | 0 | 4 |
| International Certificate of Vaccination | 31.2 | 4 | 0 |
| Bulletin of the Atomic Scientists | 31.2 | 4 | 0 |
| Mayo Clinic | 31.2 | 4 | 0 |
| Human Rights Campaign | 31.2 | 4 | 0 |
| British Poultry Science | 31.2 | 4 | 0 |
| Frontiers in Life Science: frontiers of interdisciplinary research in the life sciences | 31.2 | 4 | 0 |
| Bulletin of the World Health Organization | 31.2 | 4 | 0 |
| Journal of the American Society for Mass Spectrometry | 31.2 | 4 | 0 |
| Slavery & Abolition | 31.2 | 4 | 0 |
| Cleveland Clinic | 31.2 | 4 | 0 |
| Continuum: Journal of Media & Cultural Studies | 31.2 | 4 | 0 |
| LoopNet | 31.2 | 4 | 0 |
| Oregon Department of Consumer and Business Services | 31.2 | 4 | 0 |
| RUSI Journal | 31.2 | 4 | 0 |
| Trends in Amplification | 31.2 | 4 | 0 |
| Virology | 31.2 | 4 | 0 |
| Rice | 31.2 | 4 | 0 |
| Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare | 31.2 | 4 | 0 |
| Amino Acids | 31.2 | 4 | 0 |
| Human Resource Management Review | 31.2 | 4 | 0 |
| Public Library Quarterly | 31.2 | 4 | 0 |
| Climate and Development | 31.2 | 4 | 0 |
| Human Vaccines & Immunotherapeutics | 31.2 | 4 | 0 |
| Dermato-endocrinology | 31.2 | 4 | 0 |
| Prion | 31.2 | 4 | 0 |
| Worm | 31.2 | 4 | 0 |
| Translation (Austin, Tex.) | 31.2 | 4 | 0 |
| Journal of Asian Ceramic Societies | 31.2 | 4 | 0 |
| Journal of Enterprise Transformation | 31.2 | 4 | 0 |
| Alliant | 31.2 | 4 | 0 |
| Frontiers in Energy Efficiency | 31.2 | 4 | 0 |
| egg donation | 28.5 | 0 | 3 |
| preimplantation genetic diagnosis | 28.5 | 0 | 3 |
| Vitrification (ovocytes) | 28.5 | 0 | 3 |
| fertility clinic | 28.5 | 0 | 3 |
| third-party reproduction | 28.5 | 0 | 3 |
| Money Management International | 28.5 | 0 | 3 |
| Post-embryo transfer interventions for in vitro fertilization and intracytoplasmic sperm injection patients | 28.5 | 0 | 3 |
| Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles | 28.5 | 0 | 3 |
| Post embryo transfer interventions for in vitro fertilization / intracytoplasmic sperm injection patients | 28.5 | 0 | 3 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Day 3 versus day 2 embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation | 28.5 | 0 | 3 |
| Fertility treatment in spinal cord injury and other neurologic disease | 28.5 | 0 | 3 |
| In vitromaturation of human oocytes: Its role in infertility treatment and new possibilities | 28.5 | 0 | 3 |
| The evaluation of pre and post processing semen analysis parameters at the time of intrauterine insemination in couples diagnosed with male factor infertility and pregnancy rates based on stimulation agent. A retrospective cohort study | 28.5 | 0 | 3 |
| <i>In vitro</i> fertilization in Japan — Early days of <i>in vitro</i> fertilization and embryo transfer and future prospects for assisted reproductive technology — | 28.5 | 0 | 3 |
| Increased count, motility, and total motile sperm cells collected across three consecutive ejaculations within 24 h of oocyte retrieval: implications for management of men presenting with low numbers of motile sperm for assisted reproduction | 28.5 | 0 | 3 |
| Impact of men's dairy intake on assisted reproductive technology outcomes among couples attending a fertility clinic | 28.5 | 0 | 3 |
| Maternal whole grain intake and outcomes of in vitro fertilization | 28.5 | 0 | 3 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection. | 28.5 | 0 | 3 |
| Relationship between the sperm motility index assessed by the sperm quality analyzer and the outcome of intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Pregnancy outcome and neonatal data of children born after intracytoplasmic sperm injection with a different duration of cryopreservation of spermatozoa obtained through testicular sperm extraction | 28.5 | 0 | 3 |
| Which cut-off value of serum anti-Müllerian hormone level can predict poor ovarian reserve, poor ovarian response to stimulation andin vitrofertilization success? A prospective data analysis | 28.5 | 0 | 3 |
| Effectiveness of in vitro fertilization with preimplantation genetic screening: a reanalysis of United States assisted reproductive technology data 2011–2012 | 28.5 | 0 | 3 |
| The role of assisted hatching in in vitro fertilization: a review of the literature. A committee opinion | 28.5 | 0 | 3 |
| Fertility clinic, egg donation agency, and sperm bank policies | 28.5 | 0 | 3 |
| Intrauterine administration of recombinant human chorionic gonadotropin before embryo transfer on outcome of in vitro fertilization/ intracytoplasmic sperm injection: A randomized clinical trial | 28.5 | 0 | 3 |
| Factors influencing sperm retrieval following testicular sperm extraction in nonobstructive azoospermia patients | 28.5 | 0 | 3 |
| Assisted reproduction-in vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues | 28.5 | 0 | 3 |
| Oxidative stress resulting from exposure of a human salivary gland cells to paraoxon: An in vitro model for organophosphate oral exposure | 28.5 | 0 | 3 |
| Serum Progesterone Elevation Adversely Affects Cumulative Live Birth Rate in Different Ovarian Responders during In Vitro Fertilization and Embryo Transfer: A Large Retrospective Study | 28.5 | 0 | 3 |
| Ovarian stimulation for in-vitro fertilization/intracytoplasmic sperm injection with gonadotrophins and gonadotrophin-releasing hormone analogues: agonists and antagonists | 28.5 | 0 | 3 |
| Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH antagonist controlled ovarian stimulation protocol for patients undergoing assisted reproduction. | 28.5 | 0 | 3 |
| The influence of sperm morphology, total motile sperm count of semen and the number of motile sperm inseminated in sperm samples on the success of intrauterine insemination | 28.5 | 0 | 3 |
| Ovarian reserve tests and their utility in predicting response to controlled ovarian stimulation in rhesus monkeys | 28.5 | 0 | 3 |
| Effectiveness of in vitro fertilization with intracytoplasmic sperm injection for severe male infertility. | 28.5 | 0 | 3 |
| The importance of the cleavage stage morphology evaluation for blastocyst transfer in patients with good prognosis | 28.5 | 0 | 3 |
| Effect of male hepatitis B virus infection on outcomes of in vitro fertilization and embryo transfer treatment: insights from couples undergoing oocyte donation | 28.5 | 0 | 3 |
| Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles. | 28.5 | 0 | 3 |
| Fertility preservation outcomes may differ by cancer diagnosis | 28.5 | 0 | 3 |
| Predictive value of postwashed total progressively motile sperm count using CASA estimates in 6871 non-donor intrauterine insemination cycles | 28.5 | 0 | 3 |
| Varicocele and Male Factor Infertility Treatment: A New Meta-analysis and Review of the Role of Varicocele Repair | 28.5 | 0 | 3 |
| Combined Trifocal and Microsurgical Testicular Sperm Extraction Is the Best Technique for Testicular Sperm Retrieval in “Low-Chance” Nonobstructive Azoospermia | 28.5 | 0 | 3 |
| Assisted hatching and intracytoplasmic sperm injection are not associated with improved outcomes in assisted reproduction cycles for diminished ovarian reserve: an analysis of cycles in the United States from 2004 to 2011. | 28.5 | 0 | 3 |
| Sperm banking and assisted reproduction treatment for couples following cancer treatment of the male partner | 28.5 | 0 | 3 |
| Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. | 28.5 | 0 | 3 |
| Determining parental origin of embryo aneuploidy: analysis of genetic error observed in 305 embryos derived from anonymous donor oocyte IVF cycles | 28.5 | 0 | 3 |
| Conversion from assisted reproductive technology to intrauterine insemination in low responders: is it advantageous? | 28.5 | 0 | 3 |
| Births of normal daughters after MicroSort sperm separation and intrauterine insemination, in-vitro fertilization, or intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Embryo cryopreservation in a case of acute promyelocytic leukemia, incidentally diagnosed during ovarian stimulation for in-vitro fertilization | 28.5 | 0 | 3 |
| Successful in vitro fertilization with anonymous donor oocytes in a patient with recurrent massive hemoperitoneum following spontaneous and induced ovulation | 28.5 | 0 | 3 |
| Effect of ethnicity on live birth rates after in vitro fertilisation or intracytoplasmic sperm injection treatment. | 28.5 | 0 | 3 |
| Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis. | 28.5 | 0 | 3 |
| Establishment of comparative performance criteria for IVF centers: correlation of live birth rates in autologous and donor oocyte IVF cycles | 28.5 | 0 | 3 |
| Risk of breast cancer following fertility treatment—A registry based cohort study of parous women in Norway | 28.5 | 0 | 3 |
| Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated with diminished ovarian reserve | 28.5 | 0 | 3 |
| Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterin | 28.5 | 0 | 3 |
| Intrauterine insemination with or without mild ovarian stimulation in couples with male subfertility due to oligo/astheno- and/or teratozoospermia or antisperm antibodies: a prospective cross-over trial. | 28.5 | 0 | 3 |
| A healthy delivery of twins by assisted reproduction followed by preimplantation genetic screening in a woman with X-linked dominant incontinentia pigmenti | 28.5 | 0 | 3 |
| 8 Endocrine laboratory findings in pubertal disturbances | 28.5 | 0 | 3 |
| In vitro fertilization/intracytoplasmic sperm injection for male infertility | 28.5 | 0 | 3 |
| Can hyaluronan binding assay predict the outcome of intrauterine insemination in couples with unexplained or mild male factor infertility? | 28.5 | 0 | 3 |
| Predictive factors of successful microdissection testicular sperm extraction | 28.5 | 0 | 3 |
| The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women | 28.5 | 0 | 3 |
| Intrafollicular cortisol levels inversely correlate with cumulus cell lipid content as a possible energy source during oocyte meiotic resumption in women undergoing ovarian stimulation for in vitro fertilization | 28.5 | 0 | 3 |
| Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience | 28.5 | 0 | 3 |
| Semen Analysis in Cancer Patients Referred for Sperm Cryopreservation before Chemotherapy over a 15-Year Period in Korea | 28.5 | 0 | 3 |
| Antisperm antibodies in infertile men and their effect on semen parameters: A systematic review and meta-analysis | 28.5 | 0 | 3 |
| Application of a validated prediction model for in vitro fertilization: comparison of live birth rates and multiple birth rates with 1 embryo transferred over 2 cycles vs 2 embryos in 1 cycle | 28.5 | 0 | 3 |
| A legal-ethical analysis of reproductive endocrinologists' right to refuse ovulation induction to patients with diminished ovarian reserve | 28.5 | 0 | 3 |
| Live birth rates using conventional in vitro fertilization compared to intracytoplasmic sperm injection in Bologna poor responders with a single oocyte retrieved. | 28.5 | 0 | 3 |
| Combined strategy for fertility preservation in an oncologic patient: vitrification of in vitro matured oocytes and ovarian tissue freezing | 28.5 | 0 | 3 |
| Clinical analysis of spontaneous pregnancy reduction in the patients with multiple pregnancies undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer | 28.5 | 0 | 3 |
| Short-Term PTEN Inhibition Improves In Vitro Activation of Primordial Follicles, Preserves Follicular Viability, and Restores AMH Levels in Cryopreserved Ovarian Tissue From Cancer Patients | 28.5 | 0 | 3 |
| Varicocele and the Pathogenesis of the Associated Subfertility A Review of the Various Theories III: Theories Concerning the Deleterious Effects of Varicocele on Fertility | 28.5 | 0 | 3 |
| Does obesity have detrimental effects on IVF treatment outcomes? | 28.5 | 0 | 3 |
| Predictive value of age-specific FSH levels for IVF-ET outcome in women with normal ovarian function | 28.5 | 0 | 3 |
| Human iPS Cell-Derived Germ Cells: Current Status and Clinical Potential | 28.5 | 0 | 3 |
| Sperm chromatin structure assay (SCSA) parameters are related to fertilization, blastocyst development, and ongoing pregnancy in in vitro fertilization and intracytoplasmic sperm injection cycles | 28.5 | 0 | 3 |
| Oocyte retrieval at 140-mmHg negative aspiration pressure: A promising alternative to flushing and aspiration in assisted reproduction in women with low ovarian reserve | 28.5 | 0 | 3 |
| Patients with polycystic ovary syndrome have successful embryo arrest | 28.5 | 0 | 3 |
| Is ABO blood type associated with ovarian stimulation response in patients with diminished ovarian reserve? | 28.5 | 0 | 3 |
| Artificial oocyte activation in intracytoplasmic sperm injection cycles using testicular sperm in humanin vitrofertilization | 28.5 | 0 | 3 |
| Characterization of coal fly ash nanoparticles and their induced in vitro cellular toxicity and oxidative DNA damage in different cell lines | 28.5 | 0 | 3 |
| Management of the first in vitro fertilization cycle for unexplained infertility: a cost-effectiveness analysis of split in vitro fertilization-intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Report on management of obstructive azoospermia | 28.5 | 0 | 3 |
| Luteal phase ovarian stimulation following oocyte retrieval: is it helpful for poor responders? | 28.5 | 0 | 3 |
| Ovarian tissue and oocyte cryopreservation | 28.5 | 0 | 3 |
| Clinical application of sperm-oocyte interaction tests in in vitro fertilization--embryo transfer and intracytoplasmic sperm injection programs | 28.5 | 0 | 3 |
| Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes | 28.5 | 0 | 3 |
| Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation | 28.5 | 0 | 3 |
| Gonadotrophin ovarian stimulation and intrauterine insemination for unexplained infertility | 28.5 | 0 | 3 |
| Poor centrosomal function of cat testicular spermatozoa impairs embryo development in vitro after intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| ICSI treatment of severe male infertility can achieve prospective embryo quality compared with IVF of fertile donor sperm on sibling oocytes | 28.5 | 0 | 3 |
| Phospholipase C-zeta deficiency as a cause for repetitive oocyte fertilization failure during ovarian stimulation for in vitro fertilization with ICSI: a case report | 28.5 | 0 | 3 |
| The association of serum estradiol level with outcomes of clomiphene citrate/human menopausal gonadotropin ovarian stimulation for in vitro fertilization and embryo transfer | 28.5 | 0 | 3 |
| Pregnancy outcome of assisted reproductive technology cycle in patients with hypogonadotropic hypogonadism | 28.5 | 0 | 3 |
| Effect of endometrial biopsy on intrauterine insemination outcome in controlled ovarian stimulation cycle | 28.5 | 0 | 3 |
| Three pro-nuclei (3PN) incidence factors and clinical outcomes: a retrospective study from the fresh embryo transfer of in vitro fertilization with donor sperm (IVF-D) | 28.5 | 0 | 3 |
| Measurement of antral follicle count in patients undergoing in vitro fertilization treatment: results of a worldwide web-based survey | 28.5 | 0 | 3 |
| Oxidative stress induced sperm DNA damage, a possible reason for male infertility | 28.5 | 0 | 3 |
| Reduced in vitro fertilization of human oocytes correlates with raised circulating FSH levels during ovarian stimulation in normogonadotropic women downregulated with GnRH-analogues | 28.5 | 0 | 3 |
| The effects of sperm quality on embryo development after intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| A prospective randomized trial of conventional in vitro fertilization versus intracytoplasmic sperm injection in unexplained infertility | 28.5 | 0 | 3 |
| In vitro fertilization and intracytoplasmic sperm injection for couples with unexplained infertility after failed direct intraperitoneal insemination | 28.5 | 0 | 3 |
| The status of controlled prospective clinical trials for efficacy of intracytoplasmic sperm injection in in vitro fertilization for non-male factor infertility | 28.5 | 0 | 3 |
| Involvement of interleukin-1 and the interleukin-1 receptor antagonist in in vitro embryo development among women undergoing in vitro fertilization-embryo transfer | 28.5 | 0 | 3 |
| The outcome of sperm retrieval and intracytoplasmic sperm injection in patients with obstructive azoospermia: impact of previous tuberculous epididymitis | 28.5 | 0 | 3 |
| Intracytoplasmic sperm injection and conventional in vitro fertilization are complementary techniques in management of unexplained infertility. | 28.5 | 0 | 3 |
| Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cycles | 28.5 | 0 | 3 |
| Recruiting egg donors online: an analysis of in vitro fertilization clinic and agency websites' adherence to American Society for Reproductive Medicine guidelines | 28.5 | 0 | 3 |
| Mature oocyte retrieval during laparotomic debulking surgery following random-start controlled ovarian stimulation for fertility preservation in a patient with suspected ovarian cancer | 28.5 | 0 | 3 |
| A global perspective on assisted reproductive technology fertility treatment: an 8-country fertility specialist survey | 28.5 | 0 | 3 |
| Letrozole in a low-cost in vitro fertilization protocol in intracytoplasmic sperm injection cycles for male factor infertility: A randomized controlled trial | 28.5 | 0 | 3 |
| Identification of small segmental translocations in patients with repeated implantation failure and recurrent miscarriage using next generation sequencing after in vitro fertilization/intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Ovarian reserve markers in unexplained infertility patients treated with clomiphene citrate during intrauterine insemination | 28.5 | 0 | 3 |
| Embryo transfer in days 2 to 4 following intracytoplasmic sperm injection: a prospective cohort study | 28.5 | 0 | 3 |
| Anti-Müllerian hormone levels as a predictor of clinical pregnancy inin vitrofertilization/intracytoplasmic sperm injection-embryo transfer cycles in patients over 40 years of age | 28.5 | 0 | 3 |
| Age-Related Normogram for Ovarian Antral Follicle Count in Women with Polycystic Ovary Syndrome and Comparison with Age Matched Controls Using Magnetic Resonance Imaging | 28.5 | 0 | 3 |
| Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR) | 28.5 | 0 | 3 |
| Effect of sperm entry on blastocyst development after in vitro fertilization and intracytoplasmic sperm injection — mouse model | 28.5 | 0 | 3 |
| Improved embryo development in Japanese black cattle by in vitro fertilization using ovum pick-up plus intracytoplasmic sperm injection with dithiothreitol | 28.5 | 0 | 3 |
| Genetic considerations related to intracytoplasmic sperm injection (ICSI). | 28.5 | 0 | 3 |
| Sperm retrieval for obstructive azoospermia | 28.5 | 0 | 3 |
| Detection of Y Chromosome Microdeletion is Valuable in the Treatment of Patients With Nonobstructive Azoospermia and Oligoasthenoteratozoospermia: Sperm Retrieval Rate and Birth Rate | 28.5 | 0 | 3 |
| The role of fertility preservation in patients with endometriosis | 28.5 | 0 | 3 |
| Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval | 28.5 | 0 | 3 |
| Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve | 28.5 | 0 | 3 |
| Oxidative stress level in fresh ejaculate is not related to semen parameters or to pregnancy rates in cycles with donor oocytes | 28.5 | 0 | 3 |
| Computer-assisted semen analysis systems: comparison with routine evaluation and prognostic value in male fertility and assisted reproduction | 28.5 | 0 | 3 |
| On the Morphology of the Human Sertoli Cells under Normal Conditions and in Patients with Impaired Fertility* | 28.5 | 0 | 3 |
| In vitro maturation, fertilization, embryo development & clinical outcome of human metaphase-I oocytes retrieved from stimulated intracytoplasmic sperm injection cycles | 28.5 | 0 | 3 |
| Recent data on the treatment of unexplained infertility with clomiphene citrate, intrauterine insemination, and in vitro fertilization | 28.5 | 0 | 3 |
| Antral follicle count determines poor ovarian response better than anti-müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles | 28.5 | 0 | 3 |
| Outcomes of intracytoplasmic sperm injection using the zona pellucida-bound sperm or manually selected sperm | 28.5 | 0 | 3 |
| Cryopreservation/transplantation of ovarian tissue and in vitro maturation of follicles and oocytes: challenges for fertility preservation | 28.5 | 0 | 3 |
| The pellet swim-up is the best technique for sperm preparation during in vitro fertilization procedures | 28.5 | 0 | 3 |
| Preimplantation genetic testing: a Practice Committee opinion | 28.5 | 0 | 3 |
| Anti-mullerian hormone and antral follicle count as predictors of ovarian response in assisted reproduction | 28.5 | 0 | 3 |
| The effectiveness of earlier oocyte retrieval in the case of a premature luteinizing hormone surge on hCG day in in vitro fertilization-embryo transfer cycles | 28.5 | 0 | 3 |
| DNA fragmentation and oxidative stress compromise sperm motility and survival in late pregnancy exposure to omega-9 fatty acid in rats | 28.5 | 0 | 3 |
| Sperm quality improvement after date seed oil in vitro supplementation in spontaneous and induced oxidative stress | 28.5 | 0 | 3 |
| The correlation between male age, sperm quality and sperm DNA fragmentation in 320 men attending a fertility center | 28.5 | 0 | 3 |
| Protective effects of in vitro treatment with zinc, d-aspartate and coenzyme q10 on human sperm motility, lipid peroxidation and DNA fragmentation | 28.5 | 0 | 3 |
| Providing fertility care to men seropositive for human immunodeficiency virus: reviewing 10 years of experience and 420 consecutive cycles of in vitro fertilization and intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Determining an anti-mullerian hormone cutoff level to predict clinical pregnancy following in vitro fertilization in women with severely diminished ovarian reserve | 28.5 | 0 | 3 |
| Prevalence of chromosomal abnormalities and Y chromosome microdeletion among men with severe semen abnormalities and its correlation with successful sperm retrieval. | 28.5 | 0 | 3 |
| Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cycles | 28.5 | 0 | 3 |
| Impact of GnRH analogues on oocyte/embryo quality and embryo development in in vitro fertilization/intracytoplasmic sperm injection cycles: a case control study | 28.5 | 0 | 3 |
| Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome | 28.5 | 0 | 3 |
| A systematic review and meta-analysis to determine the effect of sperm DNA damage on in vitro fertilization and intracytoplasmic sperm injection outcome | 28.5 | 0 | 3 |
| Assessment of ovarian reserve: Anti-Mullerian hormone versus follicle stimulating hormone | 28.5 | 0 | 3 |
| The correlation of the antral follicle count and Serum anti-mullerian hormone | 28.5 | 0 | 3 |
| Anti-mullerian hormone as a predictor of ovarian reserve and ovarian response in IVF women from Gaza strip | 28.5 | 0 | 3 |
| Pregnancy outcomes and maternal and perinatal complications of pregnancies following in vitro fertilization/intracytoplasmic sperm injection using own oocytes, donor oocytes, and vitrified embryos: A prospective follow-up study | 28.5 | 0 | 3 |
| Semen preparation techniques in intrauterine insemination: A comparison of non-temperature and temperature controlled centrifugation in cases of unexplained infertility | 28.5 | 0 | 3 |
| Limb-body wall complex in one fetus of a dizygotic twin pregnancy conceived by egg donation, in vitro fertilization and embryo transfer: prenatal diagnosis and literature review | 28.5 | 0 | 3 |
| Relationship between follicular fluid adipocytokines and the quality of the oocyte and corresponding embryo development from a single dominant follicle in in vitro fertilization/intracytoplasmic sperm injection cycles | 28.5 | 0 | 3 |
| Differences in pregnancy outcomes in donor egg frozen embryo transfer (FET) cycles following preimplantation genetic screening (PGS): a single center retrospective study | 28.5 | 0 | 3 |
| Fertility-Preserving Treatment Options in Patients with Malignant Hematological Diseases | 28.5 | 0 | 3 |
| Random start or emergency IVF/in vitro maturation: a new rapid approach to fertility preservation | 28.5 | 0 | 3 |
| Clinical recommendation on fertility preservation in borderline ovarian neoplasm: ovarian stimulation and oocyte retrieval after conservative surgery | 28.5 | 0 | 3 |
| Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation | 28.5 | 0 | 3 |
| The promise of in vitro maturation in assisted reproduction and fertility preservation. | 28.5 | 0 | 3 |
| Oocyte cryopreservation for donor egg banking | 28.5 | 0 | 3 |
| Elective single-embryo transfer | 28.5 | 0 | 3 |
| Re: Varicocele and Male Factor Infertility Treatment: A New Meta-Analysis and Review of the Role of Varicocele Repair | 28.5 | 0 | 3 |
| In vitro maturation: a committee opinion | 28.5 | 0 | 3 |
| Emergency IVF versus ovarian tissue cryopreservation: decision making in fertility preservation for female cancer patients | 28.5 | 0 | 3 |
| The role of ultrasonography in in-vitro fertilization and embryo transfer (IVF-ET) | 28.5 | 0 | 3 |
| Lifestyle, Environment, and Male Reproductive Health | 28.5 | 0 | 3 |
| Semen Assessment | 28.5 | 0 | 3 |
| VACTERL association with hydrocephalus in a fetus conceived by in vitro fertilization and embryo transfer | 28.5 | 0 | 3 |
| Using contemporary microdissection testicular sperm extraction techniques, older men with nonobstructive azoospermia should not be deterred from becoming fathers | 28.5 | 0 | 3 |
| Evaluation of morphological criteria of sperm quality before in vitro fertilization and intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Cervical mucus removal before embryo transfer in women undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials. | 28.5 | 0 | 3 |
| The use of in vitro fertilization in the management of male infertility: what the urologist needs to know | 28.5 | 0 | 3 |
| Timing of human chorionic gonadotropin (hCG) hormone administration in IVF/ICSI protocols using GnRH agonist or antagonists: a systematic review and meta-analysis | 28.5 | 0 | 3 |
| Role of assisted hatching in in vitro fertilization: a guideline | 28.5 | 0 | 3 |
| Anticoagulation and in vitro fertilization and ovarian stimulation | 28.5 | 0 | 3 |
| Effect of Prednisolone Administration on Patients with Unexplained Recurrent Miscarriage and in Routine Intracytoplasmic Sperm Injection: A Meta‐Analysis | 28.5 | 0 | 3 |
| Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination | 28.5 | 0 | 3 |
| Xenotransplantation of cryopreserved human ovarian tissue—a systematic review of MII oocyte maturation and discussion of it as a realistic option for restoring fertility after cancer treatment | 28.5 | 0 | 3 |
| The importance of the length of uterine cavity, the position of the tip of the inner catheter and the distance between the fundal endometrial surface and the air bubbles as determinants of the pregnancy rate in IVF cycles | 28.5 | 0 | 3 |
| Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen–thawed embryo transfer in normal responders | 28.5 | 0 | 3 |
| An Integrated Approach to Male-Factor Subfertility: Bridging the Gap Between Fertility Specialists Trained in Urology and Gynaecology | 28.5 | 0 | 3 |
| Shifting Paradigms in Diminished Ovarian Reserve and Advanced Reproductive Age in Assisted Reproduction: Customization Instead of Conformity | 28.5 | 0 | 3 |
| The clinical efficacy and efficiency of a 100-IU starting dose of recombinant follicle stimulating hormone (Puregon) in Korean women undergoing in vitro fertilization and embryo transfer | 28.5 | 0 | 3 |
| Influence of female age on pregnancy outcome in in vitro fertilization and embryo transfer patients undergoing intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Re: Whether Sperm Deoxyribonucleic Acid Fragmentation has an Effect on Pregnancy and Miscarriage after In Vitro Fertilization/Intracytoplasmic Sperm Injection: A Systematic Review and Meta-Analysis | 28.5 | 0 | 3 |
| The outcome of in vitro fertilization and embryo transfer in women with polycystic ovary syndrome failing to conceive after ovulation induction with exogenous gonadotropins | 28.5 | 0 | 3 |
| Surrogacy: The experience of Greek commissioning women | 28.5 | 0 | 3 |
| A meta‐analysis of dehydroepiandrosterone supplementation among women with diminished ovarian reserve undergoing in vitro fertilization or intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy | 28.5 | 0 | 3 |
| Testicular Sperm Extraction and Intracytoplasmic Sperm Injection: Outcomes in a specialist fertility centre | 28.5 | 0 | 3 |
| Impact of equine assisted reproductive technologies (standard embryo transfer or intracytoplasmic sperm injection (ICSI) with in vitro culture and embryo transfer) on placenta and foal morphometry and placental gene expression. | 28.5 | 0 | 3 |
| Long-acting follicle-stimulating hormone versus daily follicle-stimulating hormone for women undergoing assisted reproduction | 28.5 | 0 | 3 |
| Infertility in advanced reproductive age. Results of in vitro fertilization and embryo transfer according to the woman's age. | 28.5 | 0 | 3 |
| Female fertility preservation strategies: cryopreservation and ovarian tissue in vitro culture, current state of the art and future perspectives | 28.5 | 0 | 3 |
| Delayed intracytoplasmic sperm injection (ICSI) with trophectoderm biopsy and preimplantation genetic screening (PGS) show increased aneuploidy rates but can lead to live births with single thawed euploid embryo transfer (STEET). | 28.5 | 0 | 3 |
| Embryo transfer techniques: an American Society for Reproductive Medicine survey of current Society for Assisted Reproductive Technology practices | 28.5 | 0 | 3 |
| Fertility Preservation Options for Men and Women With Cancer | 28.5 | 0 | 3 |
| Assisted reproduction involving gestational surrogacy: an analysis of the medical, psychosocial and legal issues: experience from a large surrogacy program | 28.5 | 0 | 3 |
| Individualization of controlled ovarian stimulation in vitro fertilization using ovarian reserve markers | 28.5 | 0 | 3 |
| Experience with 425 Subfertile Male Patients | 28.5 | 0 | 3 |
| Pregnancy After Modified Natural Cycle IVF: Case Report of a Young Patient With Elevated FSH Levels and Male Factor Infertility | 28.5 | 0 | 3 |
| Serum testosterone levels and other determinants of sperm retrieval in microdissection testicular sperm extraction | 28.5 | 0 | 3 |
| Sperm retrieval rate and pregnancy rate in infertile couples undergoing in-vitro fertilisation and testicular sperm extraction for non-obstructive azoospermia in Hong Kong. | 28.5 | 0 | 3 |
| In vitro fertilization–intracytoplasmic sperm injection outcome in patients with a markedly high DNA fragmentation index (>50%) | 28.5 | 0 | 3 |
| A comparison of models for predicting sperm retrieval before microdissection testicular sperm extraction in men with nonobstructive azoospermia | 28.5 | 0 | 3 |
| Low AMH levels as a marker of reduced ovarian reserve in young women affected by Down's syndrome. | 28.5 | 0 | 3 |
| Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria | 28.5 | 0 | 3 |
| Predictors for successful sperm retrieval of salvage microdissection testicular sperm extraction (TESE) following failed TESE in nonobstructive azoospermia patients | 28.5 | 0 | 3 |
| Normal birth after single-embryo transfer in a patient with excessive polypronuclear zygote formation following in vitro fertilization and intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Couples with unexplained subfertility and unfavorable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective single embryo transfer versus intrauterine insemination with controlled ovarian stimulation | 28.5 | 0 | 3 |
| Endometriosis, Ovarian Reserve and Live Birth Rate Following In Vitro Fertilization/Intracytoplasmic Sperm Injection | 28.5 | 0 | 3 |
| ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria | 28.5 | 0 | 3 |
| Ovarian stimulation with clomiphene and/or human menopausal gonadotropin (HMG) for in vitro fertilization (IVF) and embryo transfer (ET). | 28.5 | 0 | 3 |
| Determining the need for rescue intracytoplasmic sperm injection in partial fertilisation failure during a conventional IVF cycle | 28.5 | 0 | 3 |
| Predictive factors of successful microdissection testicular sperm extraction in patients with presumed sertoli cell-only syndrome | 28.5 | 0 | 3 |
| In vitro effect of cell phone radiation on motility, DNA fragmentation and clusterin gene expression in human sperm | 28.5 | 0 | 3 |
| Clinical outcomes of frozen-thawed single blastocyst transfer in patients requiring whole embryo freezing | 28.5 | 0 | 3 |
| Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? | 28.5 | 0 | 3 |
| Evaluation of Microdissection Testicular Sperm Extraction Results in Patients with Non-Obstructive Azoospermia: Independent Predictive Factors and Best Cutoff Values for Sperm Retrieval | 28.5 | 0 | 3 |
| Assisted reproduction policies in Israel: a retrospective analysis of in vitro fertilization–embryo transfer | 28.5 | 0 | 3 |
| Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma | 28.5 | 0 | 3 |
| Recommendations for practices utilizing gestational carriers: a committee opinion | 28.5 | 0 | 3 |
| Cumulative number and morphological score of embryos resulting in success: realistic expectations from in vitro fertilization-embryo transfer | 28.5 | 0 | 3 |
| Physical health of singleton children born after frozen embryo transfer using slow freezing: a 3-year follow-up study | 28.5 | 0 | 3 |
| Fertilization efficiency of morphologically abnormal spermatozoa in assisted reproduction is further impaired by antisperm antibodies on the male partner's sperm. | 28.5 | 0 | 3 |
| The relationship between the changes in the level of progesterone and the outcome ofin vitrofertilization-embryo transfer | 28.5 | 0 | 3 |
| Preliminary experience of the use of a gonadotrophin-releasing hormone antagonist in ovulation induction/in-vitro fertilization prior to cancer treatment | 28.5 | 0 | 3 |
| Evaluation of a cut-off value for normal sperm morphology using strict criteria to predict fertilization after conventional in-vitro fertilization and embryo transfer in asthenozoospermia | 28.5 | 0 | 3 |
| Effect of Methotrexate or Salpingectomy for Ectopic Pregnancy on Subsequent In Vitro Fertilization–Embryo Transfer Outcomes | 28.5 | 0 | 3 |
| Can the rapid identification of mature spermatozoa during microdissection testicular sperm extraction guide operative planning? | 28.5 | 0 | 3 |
| Sperm retrieval outcomes with microdissection testicular sperm extraction (micro-TESE) in men with cryptozoospermia | 28.5 | 0 | 3 |
| Conventional semen parameters and DNA fragmentation in relation to fertility status in a Greek population | 28.5 | 0 | 3 |
| Evaluation of human embryo development in in vitro fertilization- and intracytoplasmic sperm injection-fertilized oocytes: A time-lapse study | 28.5 | 0 | 3 |
| Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia | 28.5 | 0 | 3 |
| Fertility preservation for trans men: frozen-thawed in vitro matured oocytes collected at the time of ovarian tissue processing exhibit normal meiotic spindles | 28.5 | 0 | 3 |
| Fertility preservation in women of the childbearing age: Indications and strategies | 28.5 | 0 | 3 |
| Cryopreservation ofin vitromatured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy | 28.5 | 0 | 3 |
| Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval | 28.5 | 0 | 3 |
| Porcine embryo production following in vitro fertilization and intracytoplasmic sperm injection from vitrified immature oocytes matured with a granulosa cell co-culture system | 28.5 | 0 | 3 |
| The Russian experience of autotransplantation of vitrified ovarian tissue to a cancer patient | 28.5 | 0 | 3 |
| Optimal vitrification protocol for mouse ovarian tissue cryopreservation: effect of cryoprotective agents and in vitro culture on vitrified-warmed ovarian tissue survival | 28.5 | 0 | 3 |
| Effects of frozen timing on the spindle density, the angle between the polar body and spindle, and embryo development of intracytoplasmic sperm injection in mouse mature oocytes | 28.5 | 0 | 3 |
| Mature oocyte cryopreservation: a guideline | 28.5 | 0 | 3 |
| Fertility preservation by ovarian stimulation and oocyte cryopreservation in a 14-year-old adolescent with Turner syndrome mosaicism and impending premature ovarian failure | 28.5 | 0 | 3 |
| Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation | 28.5 | 0 | 3 |
| Economic evaluation of elective single-embryo transfer with subsequent single frozen embryo transfer in an in vitro fertilization/intracytoplasmic sperm injection program | 28.5 | 0 | 3 |
| Sibling embryo blastocyst development correlates with the in vitro fertilization day 3 embryo transfer pregnancy rate in patients under age 40. | 28.5 | 0 | 3 |
| Effect of embryo freezing on perinatal outcome after assisted reproduction techniques: lessons from the Latin American Registry of Assisted Reproduction | 28.5 | 0 | 3 |
| Depression and coping strategies of Chinese women undergoing in-vitro fertilization | 28.5 | 0 | 3 |
| Recommendations for development of an emergency plan for in vitro fertilization programs: a committee opinion | 28.5 | 0 | 3 |
| Guidelines for development of an emergency plan for in vitro fertilization programs | 28.5 | 0 | 3 |
| Chinese student donors could be a reference population when monitoring sperm quality | 28.5 | 0 | 3 |
| Ovarian stimulation and corpus luteum function in human in vitro fertilization and embryo transfer | 28.5 | 0 | 3 |
| Ketotifen improves sperm motility and sperm morphology in male patients with leukocytospermia and unexplained infertility | 28.5 | 0 | 3 |
| ICSI significantly improved the pregnancy rate of patients with a high sperm DNA fragmentation index | 28.5 | 0 | 3 |
| Tiaogeng Yijing decoction improves the pregnancy outcomes of patients with poor ovarian response undergoing in vitro fertilization-embryo transfer | 28.5 | 0 | 3 |
| The effect of human chorionic gonadotropin-based hormonal therapy on intratesticular testosterone levels and spermatogonial DNA synthesis in men with non-obstructive azoospermia | 28.5 | 0 | 3 |
| Effect of sperm DNA fragmentation on the clinical outcomes for in vitro fertilization and intracytoplasmic sperm injection in women with different ovarian reserves. | 28.5 | 0 | 3 |
| Prospective evaluation of basal stromal Doppler studies in women with good ovarian reserve and infertility undergoing in vitro fertilization-embryo transfer treatment: patients with polycystic ovary syndrome versus ovulatory patients. | 28.5 | 0 | 3 |
| Prognosis of oocyte donation cycles: a prospective comparison of the in vitro fertilization-embryo transfer cycles of recipients who used shared oocytes versus those who used altruistic donors | 28.5 | 0 | 3 |
| Comparison of pregnancy rates following in vitro fertilization-embryo transfer between the donors and the recipients in a donor oocyte program | 28.5 | 0 | 3 |
| Impact of age on semen parameters in male partners of infertile couples in a rural tertiary care center of central India: A cross-sectional study | 28.5 | 0 | 3 |
| Further evidence supports the clinical utility of sperm DNA fragmentation testing in male infertility workup and assisted reproductive technology | 28.5 | 0 | 3 |
| First French live-birth after oocyte vitrification performed before chemotherapy for fertility preservation | 28.5 | 0 | 3 |
| Use of recombinant human luteinizing hormone for ovulation stimulation in in vitro fertilization-embryo transfer | 28.5 | 0 | 3 |
| Laparoscopic ovarian cystectomy of endometriomas: surgeons’ experience may affect ovarian reserve and live-born rate in infertile patients with in vitro fertilization-intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Comparison of Alarelin and Triptorelin in the long-protocol ovulation induction in in vitro fertilization and embryo transfer | 28.5 | 0 | 3 |
| Assisted reproduction: an important review of the literature on the risk of malformation after in vitro fertilization and intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women aged < 37, undergoing ovulation induction with human FSH compared with recombinant FSH: a randomised controlled study | 28.5 | 0 | 3 |
| Myotonic dystrophy type 1 and PGD: ovarian stimulation response and correlation analysis between ovarian reserve and genotype | 28.5 | 0 | 3 |
| Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study. | 28.5 | 0 | 3 |
| Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients | 28.5 | 0 | 3 |
| Effects of permethrin, cypermethrin and 3-phenoxybenzoic acid on rat sperm motility in vitro evaluated with computer-assisted sperm analysis | 28.5 | 0 | 3 |
| Effects of electroacupuncture on in vitro fertilization-embryo transfer (IVF-ET) of patients with poor ovarian response | 28.5 | 0 | 3 |
| Comparison of the Outcome of Conventional in vitro Fertilization and Intracytoplasmic Sperm Injection in Moderate Male Infertility from Ejaculate | 28.5 | 0 | 3 |
| Effect of the number of inseminating sperm and the follicular stimulation protocol on in vitro fertilization of human oocytes in male factor and non-male factor couples | 28.5 | 0 | 3 |
| Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization--embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Repetitive oocyte donation: a committee opinion | 28.5 | 0 | 3 |
| Follicle measurements using sonography-based automated volume count accurately predict the yield of mature oocytes in in vitro fertilization/intracytoplasmic sperm injection cycles | 28.5 | 0 | 3 |
| Effects of follicle stimulating hormone (FSH) on follicular development, oocyte retrieval, and in vitro fertilization (IVF) in ewes during breeding season and seasonal anestrus | 28.5 | 0 | 3 |
| Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist | 28.5 | 0 | 3 |
| Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve | 28.5 | 0 | 3 |
| The impact of surgical sperm retrieval on the in vitro fertilization outcomes of infertile patients with temporary ejaculation failure on their oocyte retrieval day | 28.5 | 0 | 3 |
| Successful pregnancy using known donor oocytes fertilized in vitro by spermatozoa obtained by electro-ejaculation from a quadriplegic husband | 28.5 | 0 | 3 |
| The relationship between endogenous oestradiol and vitamin D3 metabolites in serum and follicular fluid during ovarian stimulation for in-vitro fertilization and embryo transfer | 28.5 | 0 | 3 |
| Ovarian stimulation in intrauterine insemination with donor sperm: a randomized study comparing clomiphene citrate in fixed protocol versus highly purified urinary FSH. | 28.5 | 0 | 3 |
| Fertilization and embryo development with spermatozoa obtained from testicular sperm extraction into oocytes generated from human chorionic gonadotropin-primed in vitro maturation cycles | 28.5 | 0 | 3 |
| Re: In Vitro Fertilization-Intracytoplasmic Sperm Injection Outcome in Patients with a Markedly High DNA Fragmentation Index (>50%) | 28.5 | 0 | 3 |
| Intrauterine insemination with frozen donor sperm. Pregnancy outcome in relation to age and ovarian stimulation regime | 28.5 | 0 | 3 |
| Impact of ketorolac administration around ovarian stimulation onin vivoandin vitrofertilization and subsequent embryo development | 28.5 | 0 | 3 |
| Cycle-specific and cumulative fecundity in patients with endometriosis who are undergoing controlled ovarian hyperstimulation-intrauterine insemination or in vitro fertilization-embryo transfer | 28.5 | 0 | 3 |
| Prevalence of low sperm count and abnormal semen parameters in male partners of women consulting at infertility clinic in Abakaliki, Nigeria | 28.5 | 0 | 3 |
| Impact of high response of ovary to gonadotropin stimulation on the outcome of in vitro fertilization and embryo transfer or intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen | 28.5 | 0 | 3 |
| Personal experience with ovarian stimulation in an in vitro fertilization and embryo transfer program | 28.5 | 0 | 3 |
| Relationship of antisperm antibodies to oocyte fertilization in in vitro fertilization-embryo transfer | 28.5 | 0 | 3 |
| Optimal treatment for poor responders to ovarian stimulation: does in vitro insemination offer any advantages to intrauterine insemination? | 28.5 | 0 | 3 |
| Effect of ethnicity on live birth rates after in vitro fertilisation or intracytoplasmic sperm injection treatment: possible explanations and further observations | 28.5 | 0 | 3 |
| Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer | 28.5 | 0 | 3 |
| Standardization and quality control of sperm concentration and sperm motility counts in semen analysis | 28.5 | 0 | 3 |
| Serial follow-up study of serum testosterone and antisperm antibodies in patients with non-obstructive azoospermia after conventional or microdissection testicular sperm extraction | 28.5 | 0 | 3 |
| Twin pregnancy outcome among cases of spontaneous conception, intrauterine insemination, and in vitro fertilization/intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Pure human follicle stimulating hormone has a role in the treatment of severe male infertility by assisted reproduction: Norfolk's total experience | 28.5 | 0 | 3 |
| Determination of legal parentage in egg donation, embryo transplantation, and gestational surrogacy arrangements | 28.5 | 0 | 3 |
| Ovarian stimulation for in vitro fertilization in low-responder patients using pulsatile intravenous follicle stimulating hormone | 28.5 | 0 | 3 |
| Authors' reply: Effect of ethnicity on live birth rates after in vitro fertilisation or intracytoplasmic sperm injection treatment: possible explanations and further observations. | 28.5 | 0 | 3 |
| Gonadotropin stimulation for in vitro fertilization and embryo transfer in insulin-dependent diabetics: follicular response, oocyte quality, embryo development, and follicular environment | 28.5 | 0 | 3 |
| Serum testosterone levels in patients with nonmosaic Klinefelter syndrome after testicular sperm extraction for intracytoplasmic sperm injection. | 28.5 | 0 | 3 |
| Comparison of clinical outcome of mild-stimulation and conventional ovarian stimulation in in vitro fertilization-embryo transfer (IVF-ET) | 28.5 | 0 | 3 |
| Spontaneous luteinizing hormone (LH) surges are associated with more rapidly increasing estradiol (E2) and follicle stimulating hormone (FSH) in in vitro fertilization and embryo transfer | 28.5 | 0 | 3 |
| Perspective on in vitro fertilization and embryo transfer. Stimulus for biomedical research in reproductive medicine | 28.5 | 0 | 3 |
| Paternal body mass index is associated with decreased blastocyst development and reduced live birth rates following assisted reproductive technology | 28.5 | 0 | 3 |
| Risk-sharing or refund programs in assisted reproduction: a committee opinion | 28.5 | 0 | 3 |
| Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility. | 28.5 | 0 | 3 |
| Reproductive potential of men with obstructive azoospermia undergoing percutaneous sperm retrieval and intracytoplasmic sperm injection according to the cause of obstruction | 28.5 | 0 | 3 |
| Preovulatory follicular fluid: relationships to ovarian stimulation protocol, fertilization, and sperm penetration in vitro | 28.5 | 0 | 3 |
| Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level | 28.5 | 0 | 3 |
| Sperm washing and intrauterine insemination for cervical factor, oligospermia, immunologic infertility and unexplained infertility | 28.5 | 0 | 3 |
| Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial | 28.5 | 0 | 3 |
| First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient | 28.5 | 0 | 3 |
| Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy | 28.5 | 0 | 3 |
| Comparison of the efficacy of treating sperm with low hypoosmotic swelling test scores with chymotrypsin followed by intrauterine insemination vs in vitro fertilization with intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Synchronous sperm retrieval and sperm washing in an intracytoplasmic sperm injection cycle in an azoospermic man who was positive for human immunodeficiency virus | 28.5 | 0 | 3 |
| Re: Sperm retrieval rates and intracytoplasmic sperm injection outcomes for men with non-obstructive azoospermia and the health of resulting offspring. | 28.5 | 0 | 3 |
| Ameliorative effects of melatonin against hydrogen peroxide-induced oxidative stress on boar sperm characteristics and subsequent in vitro embryo development | 28.5 | 0 | 3 |
| Prevalence and Predictors of Sperm Banking in Adolescents Newly Diagnosed With Cancer: Examination of Adolescent, Parent, and Provider Factors Influencing Fertility Preservation Outcomes | 28.5 | 0 | 3 |
| Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction-intrauterine insemination to in vitro fertilization conversions, independent of age and estradiol level on the day of human chorionic g | 28.5 | 0 | 3 |
| Obstetric outcomes in donor oocyte pregnancies compared with advanced maternal age in in vitro fertilization pregnancies | 28.5 | 0 | 3 |
| ANDROLOGY: Relationships Between Sperm Motility Characteristics Assessed by the Computer-Aided Sperm Analysis (CASA) and Fertilization Rates In Vitro | 28.5 | 0 | 3 |
| Fertility preservation for men with testicular cancer: Is sperm cryopreservation cost effective in the era of assisted reproductive technology? | 28.5 | 0 | 3 |
| Revisiting The Relationship between The Ejaculatory Abstinence Period and Semen Characteristics | 28.5 | 0 | 3 |
| Ovarian stimulation, egg aspiration, in vitro fertilization and embryo transfer in the baboon (Papio anubis): a pilot project at the Institute of Primate Research, Nairobi, Kenya | 28.5 | 0 | 3 |
| Single layer centrifugation of fresh dromedary camel semen improves sperm quality and in vitro fertilization capacity compared with simple sperm washing. | 28.5 | 0 | 3 |
| Intrauterine insemination with washed capacitated sperm cells in the treatment of male factor, cervical factor and unexplained infertility. | 28.5 | 0 | 3 |
| Analysis of pregnancy outcomes after in vitro fertilization-embryo transfer and intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| The role of oxidative stress in female infertility and in vitro fertilization. | 28.5 | 0 | 3 |
| Intracytoplasmic sperm injection and conventional in vitro fertilization for sibling oocytes in cases of unexplained infertility and borderline semen | 28.5 | 0 | 3 |
| Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation | 28.5 | 0 | 3 |
| The effect of elevated progesterone levels before oocyte retrieval in women undergoing ovarian stimulation for IVF treatment on the genomic profile of peri-implantation endometrium. | 28.5 | 0 | 3 |
| Supplementation with nanomolar concentrations of verbascoside during in vitro maturation improves embryo development by protecting the oocyte against oxidative stress: a large animal model study | 28.5 | 0 | 3 |
| The effect of varying inseminating sperm concentration in male factor and non-male factor infertility during in vitro fertilization. | 28.5 | 0 | 3 |
| Estimating live birth rates after ovulation induction in polycystic ovary syndrome: sample size calculations for the pregnancy in polycystic ovary syndrome trial | 28.5 | 0 | 3 |
| Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation | 28.5 | 0 | 3 |
| Serum level of anti-mullerian hormone in early follicular phase as a predictor of ovarian reserve and pregnancy outcome in assisted reproductive technology cycles | 28.5 | 0 | 3 |
| Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization outcome in an egg donation program | 28.5 | 0 | 3 |
| Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation? | 28.5 | 0 | 3 |
| Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? | 28.5 | 0 | 3 |
| Effect of ultrasound-guided aspiration of hydrosalpingeal fluid during oocyte retrieval on the outcomes of in vitro fertilisation-embryo transfer: a randomised controlled trial (NCT01040351). | 28.5 | 0 | 3 |
| Retracted: Cervical mucus removal prior to intrauterine insemination: a randomized trial | 28.5 | 0 | 3 |
| The significance of antral follicle count in controlled ovarian stimulation and intrauterine insemination | 28.5 | 0 | 3 |
| Effects of fenvalerate and cypermethrin on rat sperm motility patterns in vitro as measured by computer-assisted sperm analysis | 28.5 | 0 | 3 |
| Fertility preservation with ovarian stimulation protocols prior to cancer treatment | 28.5 | 0 | 3 |
| Racial Disparities in Fertility Care: an Analysis of 4537 Intrauterine Insemination Cycles | 28.5 | 0 | 3 |
| Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer | 28.5 | 0 | 3 |
| Three successful pregnancies with in vitro fertilization embryo transfer over an eight year time span despite elevated basal serum follicle stimulating hormone levels. Case report | 28.5 | 0 | 3 |
| Glutathione and cysteine enhance porcine preimplantation embryo development in vitro after intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| A controlled study between the use of gamete intrafallopian transfer (GIFT) and in vitro fertilization and embryo transfer in the management of idiopathic and male infertility | 28.5 | 0 | 3 |
| Anti-Mullerian Hormone-to-Testosterone Ratio is Predictive of Positive Sperm Retrieval in Men with Idiopathic Non-Obstructive Azoospermia. | 28.5 | 0 | 3 |
| Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial | 28.5 | 0 | 3 |
| Reprotoxicity of intrauterine insemination and in vitro fertilization-embryo transfer disposables and products: a 4-year survey | 28.5 | 0 | 3 |
| Congenital Malformations in Singleton Infants Conceived by Assisted Reproductive Technologies and Singleton Infants by Natural Conception in Tehran, Iran | 28.5 | 0 | 3 |
| Endometrial biopsy during hormone replacement cycle in donor oocyte recipients before in vitro fertilization-embryo transfer | 28.5 | 0 | 3 |
| Oocyte donation in low responders to conventional ovarian stimulation for in vitro fertilization. | 28.5 | 0 | 3 |
| Living Kinship Trouble: Danish Sperm Donors’ Narratives of Relatedness | 28.5 | 0 | 3 |
| Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). | 28.5 | 0 | 3 |
| Live birth rates after combined adjuvant therapy in IVF–ICSI cycles: a matched case-control study | 28.5 | 0 | 3 |
| Effects of transcutaneous electrical acupoint stimulation on ovarian reserve of patients with diminished ovarian reserve in in vitro fertilization and embryo transfer cycles | 28.5 | 0 | 3 |
| Financial "risk-sharing" or refund programs in assisted reproduction: an Ethics Committee opinion | 28.5 | 0 | 3 |
| Oocyte or embryo donation to women of advanced reproductive age: an Ethics Committee opinion | 28.5 | 0 | 3 |
| Men With Severe Oligospermia Appear to Benefit From Varicocele Repair: A Cost-effectiveness Analysis of Assisted Reproductive Technology | 28.5 | 0 | 3 |
| High gonadotropin dosage does not affect euploidy and pregnancy rates in IVF PGS cycles with single embryo transfer | 28.5 | 0 | 3 |
| Donor Motivations, Associated Risks and Ethical Considerations of Oocyte Donation | 28.5 | 0 | 3 |
| Salvage hormonal therapy after failed microdissection testicular sperm extraction: A multi‐institutional prospective study | 28.5 | 0 | 3 |
| The impact of ovarian stimulation protocol on oocyte quality, subsequent in vitro embryo development, and pregnancy after transfer to recipients in Eld's deer (Rucervus eldii thamin). | 28.5 | 0 | 3 |
| A Focus on Maternal Health Before Assisted Reproduction: Results From a Pilot Survey of Canadian IVF Medical Directors | 28.5 | 0 | 3 |
| Effect of male body mass index on live-birth sex ratio of singletons after assisted reproduction technology | 28.5 | 0 | 3 |
| Reproductive Ethics in Commercial Surrogacy: Decision-Making in IVF Clinics in New Delhi, India | 28.5 | 0 | 3 |
| Impact of early cleaved zygote morphology on embryo development and in vitro fertilization-embryo transfer outcome: a prospective study | 28.5 | 0 | 3 |
| The use of luteal-phase ovarian stimulation for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment | 28.5 | 0 | 3 |
| Effect of premature serum progesterone rise on embryo transfer outcomes and the role of blastocyst culture and transfer in assisted reproductive technology cycles with premature progesterone rise | 28.5 | 0 | 3 |
| Progestin-primed ovarian stimulation with or without clomiphene citrate supplementation in normal ovulatory women undergoing in vitro fertilization/intracytoplasmic sperm injection: A prospective randomized controlled trial. | 28.5 | 0 | 3 |
| The influence of sperm motility and cryopreservation on the treatment outcome after intracytoplasmic sperm injection following testicular sperm extraction. | 28.5 | 0 | 3 |
| Human sperm handling in intracytoplasmic sperm injection processes: In vitro studies on mouse oocyte activation, embryo development competence and sperm oxidation-reduction potential | 28.5 | 0 | 3 |
| Ovulation induction and oocyte retrieval for fertility preservation in young adolescents newly diagnosed with medulloblastoma: a case series | 28.5 | 0 | 3 |
| Melatonin concentration in follicular fluid is correlated with antral follicle count (AFC) and in vitro fertilization (IVF) outcomes in women undergoing assisted reproductive technology (ART) procedures. | 28.5 | 0 | 3 |
| Initial maternal serum human chorionic gonadotropin levels in pregnancies achieved after assisted reproductive technology are higher after preimplantation genetic screening and after frozen embryo transfer: a retrospective cohort | 28.5 | 0 | 3 |
| There is no evidence that the time from egg retrieval to embryo transfer affects live birth rates in a freeze-all strategy | 28.5 | 0 | 3 |
| The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age. | 28.5 | 0 | 3 |
| Use of donor sperm in addition to oocyte donation after repeated implantation failure in normozoospermic patients does not improve live birth rates | 28.5 | 0 | 3 |
| Comparison between follicular stimulation and luteal stimulation protocols with clomiphene and HMG in women with poor ovarian response | 28.5 | 0 | 3 |
| BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles | 28.5 | 0 | 3 |
| Ovarian stimulation for oocyte cryopreservation for prevention of age-related fertility loss: one in five is a low responder | 28.5 | 0 | 3 |
| Live birth rates after IVF are lower with frozen donor eggs, study shows: | 28.5 | 0 | 3 |
| Differential expression of vascular endothelial growth factor angiogenic factors in different endometrial compartments in women who have an elevated progesterone level before oocyte retrieval, during in vitro fertilization-embryo transfer treatment | 28.5 | 0 | 3 |
| Effect of endometrial thickness on pregnancy outcome after intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Ureteric Injury During Transvaginal Ultrasound Guided Oocyte Retrieval | 28.5 | 0 | 3 |
| Does ovarian reserve predict egg quality in unstimulated therapeutic donor insemination cycles? | 28.5 | 0 | 3 |
| Live birth in a 50-year-old woman following in vitro fertilization–embryo transfer with autologous oocytes: a rare case report | 28.5 | 0 | 3 |
| Live birth rate with repeat microdissection TESE and intracytoplasmic sperm injection after a conventional testicular biopsy in men with nonobstructive azoospermia | 28.5 | 0 | 3 |
| Maternal KIR haplotype influences live birth rate after double embryo transfer in IVF cycles in patients with recurrent miscarriages and implantation failure | 28.5 | 0 | 3 |
| Ovarian and adrenal androgens may be useful markers to predict oocyte competence and embryo development in older women | 28.5 | 0 | 3 |
| Fertility preservation in the transgender patient: expanding oncofertility care beyond cancer | 28.5 | 0 | 3 |
| Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET | 28.5 | 0 | 3 |
| Comparison of estradiol and progesterone priming/antagonist/letrozole and microdose flare-up protocols for poor responders undergoing intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Embryo quality in controlled ovarian stimulation forin vitrofertilization in young poor responders | 28.5 | 0 | 3 |
| Role of dehydroepiandrosterone in improving oocyte and embryo quality in IVF cycles | 28.5 | 0 | 3 |
| Pregnancy outcomes decline in recipients over age 44: an analysis of 27,959 fresh donor oocyte in vitro fertilization cycles from the Society for Assisted Reproductive Technology | 28.5 | 0 | 3 |
| Effects of different oocyte retrieval and in vitro maturation systems on bovine embryo development and quality | 28.5 | 0 | 3 |
| What is the quality of information on social oocyte cryopreservation provided by websites of Society for Assisted Reproductive Technology member fertility clinics? | 28.5 | 0 | 3 |
| Influence of bovine sperm DNA fragmentation and oxidative stress on early embryo in vitro development outcome | 28.5 | 0 | 3 |
| Re: The Impact of Surgical Sperm Retrieval on the In Vitro Fertilization Outcomes of Infertile Patients with Temporary Ejaculation Failure on their Oocyte Retrieval Day | 28.5 | 0 | 3 |
| Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonis | 28.5 | 0 | 3 |
| Prospective analysis of ovarian reserve markers as determinant in response to controlled ovarian stimulation in women undergoing IVF cycles in low resource setting in India | 28.5 | 0 | 3 |
| Insulin resistance does not affect early embryo development but lowers implantation rate in in vitro maturation–in vitro fertilization–embryo transfer cycle | 28.5 | 0 | 3 |
| Recommendations for gamete and embryo donation: a committee opinion | 28.5 | 0 | 3 |
| Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure | 28.5 | 0 | 3 |
| Oocyte cryopreservation following failed testicular sperm extraction: a French case report with implications for the management of non-obstructive azoospermia | 28.5 | 0 | 3 |
| Effect of oocyte quality on blastocyst development after in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) in a sheep model. | 28.5 | 0 | 3 |
| Impact of highly purified versus recombinant follicle stimulating hormone on oocyte quality and embryo development in intracytoplasmic sperm injection cycles | 28.5 | 0 | 3 |
| Ureteral injury after transvaginal ultrasound-guided oocyte retrieval: a complication of in vitro fertilization-embryo transfer that may lurk undetected in women presenting with severe ovarian hyperstimulation syndrome | 28.5 | 0 | 3 |
| Outcome of cycles of oocyte in vitro maturation requiring testicular sperm extraction for nonobstructive azoospermia | 28.5 | 0 | 3 |
| Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study | 28.5 | 0 | 3 |
| In vitro fertilization–intracytoplasmic sperm injection outcomes in single- versus double-lumen oocyte retrieval needles in normally responding patients: a randomized trial | 28.5 | 0 | 3 |
| Improving fertility preservation in cancer: ovarian tissue cryobanking followed by ovarian stimulation can be efficiently combined. | 28.5 | 0 | 3 |
| Ovarian stimulation, in vitro fertilization, and effects of culture conditions on baboon preimplantation embryo development | 28.5 | 0 | 3 |
| Overweight and obesity negatively affect the outcomes of ovarian stimulation andin vitrofertilisation: a cohort study of 2628 Chinese women | 28.5 | 0 | 3 |
| Pregnancy rates per embryo transfer (ET) may be improved by conventional oocyte insemination for male factor rather than intracytoplasmic sperm injection (ICSI). | 28.5 | 0 | 3 |
| Comparison of in vitro fertilization versus intracytoplasmic sperm injection in extremely low oocyte retrieval cycles | 28.5 | 0 | 3 |
| 2008 Guidelines for gamete and embryo donation: a Practice Committee report | 28.5 | 0 | 3 |
| Essential elements of informed consent for elective oocyte cryopreservation: a Practice Committee opinion | 28.5 | 0 | 3 |
| Comparative study of intracytoplasmic sperm injection and in vitro fertilization with high insemination concentration in sibling oocytes in the treatment of unexplained infertility. | 28.5 | 0 | 3 |
| Developmental potential of oocytes fertilized by conventional in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) after cryopreservation and mesometrial autotransplantation of rabbit ovarian tissue | 28.5 | 0 | 3 |
| Improved pregnancy outcome for women with decreased ovarian oocyte reserve and advanced reproductive age by performing in vitro fertilization-embryo transfer | 28.5 | 0 | 3 |
| Guidelines for development of an emergency plan for in vitro fertilization programs | 28.5 | 0 | 3 |
| Male age negatively impacts embryo development and reproductive outcome in donor oocyte assisted reproductive technology cycles | 28.5 | 0 | 3 |
| The significance of sperm DNA oxidation in embryo development and reproductive outcome in an oocyte donation program: a new model to study a male infertility prognostic factor | 28.5 | 0 | 3 |
| Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles | 28.5 | 0 | 3 |
| Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation | 28.5 | 0 | 3 |
| Testicular sperm extraction with intracytoplasmic sperm injection is successful for the treatment of nonobstructive azoospermia associated with cryptorchidism | 28.5 | 0 | 3 |
| Estimation of the contribution of non-assisted reproductive technology ovulation stimulation fertility treatments to US singleton and multiple births | 28.5 | 0 | 3 |
| Prognosis following in vitro fertilization-embryo transfer (IVF-ET) in patients with elevated day 2 or 3 serum follicle stimulating hormone (FSH) is better in younger vs older patients | 28.5 | 0 | 3 |
| The outcome of sperm retrieval and intracytoplasmic sperm injection for obstructive azoospermia | 28.5 | 0 | 3 |
| Relationships between sperm motility characteristics assessed by the computer-aided sperm analysis (CASA) and fertilization rates in vitro | 28.5 | 0 | 3 |
| Massive retroperitoneal bleeding: a complication of transvaginal ultrasonography-guided oocyte retrieval for in vitro fertilization-embryo transfer | 28.5 | 0 | 3 |
| Good results of milder form of ovarian stimulation in an in vitro fertilization/intracytoplasmic sperm injection program | 28.5 | 0 | 3 |
| Intracytoplasmic sperm injection is not associated with poor outcome in couples with normal semen parameters and previous idiopathic fertilization failure in conventional in vitro fertilization | 28.5 | 0 | 3 |
| The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Clinical application of intracytoplasmic sperm injection using in vitro cultured testicular spermatozoa obtained the day before egg retrieval | 28.5 | 0 | 3 |
| The outcome of in-vitro fertilization treatment by egg donation and intracytoplasmatic sperm injection for severe male factor infertility: a preliminary report | 28.5 | 0 | 3 |
| Outcome from consecutive in-vitro fertilization/intracytoplasmic sperm injection attempts in the final group treated with urinary gonadotrophins and the first group treated with recombinant follicle stimulating hormone | 28.5 | 0 | 3 |
| Multinucleation in normally fertilized embryos is associated with an accelerated ovulation induction response and lower implantation and pregnancy rates in in vitro fertilization-embryo transfer cycles | 28.5 | 0 | 3 |
| Surgical sperm retrieval and intracytoplasmic sperm injection as treatment of obstructive azoospermia | 28.5 | 0 | 3 |
| Sperm Morphology Evaluated by Computer (IVOS) Cannot Predict the Fertilization Rate In Vitro after Intracytoplasmic Sperm Injection | 28.5 | 0 | 3 |
| Pregnancy After Human Donor Oocyte Cryopreservation and Thawing in Association with Intracytoplasmic Sperm Injection in a Patient with Ovarian Failure | 28.5 | 0 | 3 |
| Improved clinical outcomes for in vitro fertilization with delay of embryo transfer from 48 to 72 hours after oocyte retrieval: use of glucose- and phosphate-free media | 28.5 | 0 | 3 |
| Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserelin acetate-induced pituitary desensitization on ovarian response to exogenous gonadotrophins in an in-vitro fertilization and embryo transfer programme | 28.5 | 0 | 3 |
| The relationship between sperm morphology and rates of fertilization, pregnancy and spontaneous abortion in an in-vitro fertilization/intracytoplasmic sperm injection programme | 28.5 | 0 | 3 |
| Avoidance of oocyte retrieval on the weekend through the use of scheduled ovarian hyperstimulation for in vitro fertilization and embryo transfer | 28.5 | 0 | 3 |
| Testicular sperm retrieval by percutaneous fine needle sperm aspiration compared with testicular sperm extraction by open biopsy in men with non-obstructive azoospermia | 28.5 | 0 | 3 |
| Parameters that influence the results of in vitro fertilization/embryo transfer: a study of an egg donation model | 28.5 | 0 | 3 |
| Prospective controlled randomized study of in vitro fertilization versus intracytoplasmic sperm injection in the treatment of tubal factor infertility with normal semen parameters. | 28.5 | 0 | 3 |
| High implantation and pregnancy rates with testicular sperm extraction and intracytoplasmic sperm injection in obstructive and non-obstructive azoospermia | 28.5 | 0 | 3 |
| Oocyte donation programme: results obtained with intracytoplasmic sperm injection in cases of severe male factor infertility or previous failed fertilization | 28.5 | 0 | 3 |
| Success of donor oocyte in in vitro fertilization-embryo transfer in recipients with and without premature ovarian failure | 28.5 | 0 | 3 |
| High rates of perforation are found in endovaginal ultrasound probe covers before and after oocyte retrieval for in vitro fertilization-embryo transfer | 28.5 | 0 | 3 |
| Severe ovarian hyperstimulation despite prophylactic albumin at the time of oocyte retrieval for in vitro fertilization and embryo transfer | 28.5 | 0 | 3 |
| Pregnancies after testicular sperm extraction and intracytoplasmic sperm injection in non-obstructive azoospermia | 28.5 | 0 | 3 |
| Endocrinology: Endogenous plasma growth hormone and the occurrence of pregnancies in patients undergoing in-vitro fertilization and embryo transfer with ovarian stimulation | 28.5 | 0 | 3 |
| Controversies in assisted reproduction: oocyte donation. Protocols for egg donation | 28.5 | 0 | 3 |
| Selection of ovarian stimulation protocol is related to IVF treatment outcome in women 35 years of age and older | 28.5 | 0 | 3 |
| Embryos cultured in vitro with multinucleated blastomeres have poor implantation potential in human in-vitro fertilization and intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Ultrasonic control without hormone determination for ovulation induction in in-vitro fertilization/embryo transfer with gonadotrophin-releasing hormone analogue and human menopausal gonadotrophin | 28.5 | 0 | 3 |
| Outcome of donor versus husband insemination in couples with unexplained infertility treated by in vitro fertilization and embryo transfer | 28.5 | 0 | 3 |
| Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation | 28.5 | 0 | 3 |
| Bilateral salpingectomy does not compromise ovarian stimulation in an in-vitro fertilization/embryo transfer programme | 28.5 | 0 | 3 |
| A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program | 28.5 | 0 | 3 |
| The effect of endometrial thickness and echo pattern on in vitro fertilization outcome in donor oocyte-embryo transfer cycle. | 28.5 | 0 | 3 |
| Sperm retrieval by microdissection testicular sperm extraction and intracytoplasmic sperm injection outcomes in nonobstructive azoospermic patients with Klinefelter syndrome. | 28.5 | 0 | 3 |
| Infertility treatment strategy involving combined freeze-all embryos and single vitrified-warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism | 28.5 | 0 | 3 |
| IVF and endometriosis, oocyte donation and fertility preservation | 28.5 | 0 | 3 |
| Effect of oxygen concentration on outcome of in-vitro fertilization-embryo transfer | 28.5 | 0 | 3 |
| Application of microdissection testicular sperm extraction in non-obstructive azoospermia | 28.5 | 0 | 3 |
| The significance of blastocyst culture for discarded embryos in the treatment period of in-vitro fertilization and embryo transfer without available embryos | 28.5 | 0 | 3 |
| Male Infertility Diagnosis and Treatment in the Era of In Vitro Fertilization and Intracytoplasmic Sperm Injection | 28.5 | 0 | 3 |
| CLINICAL ASSISTED REPRODUCTION: Comparison of Recombinant and Urinary Follicle-Stimulating Hormone Preparations in Short-Term Gonadotropin Releasing Hormone Agonist Protocol for In Vitro Fertilization-Embryo Transfer | 28.5 | 0 | 3 |
| Outcome of Oocyte Vitrification Combined with Microdissection Testicular Sperm Extraction and Aspiration for Assisted Reproduction in Men. | 28.5 | 0 | 3 |
| Intrafollicular soluble RAGE benefits embryo development and predicts clinical pregnancy in infertile patients of advanced maternal age undergoing in vitro fertilization | 28.5 | 0 | 3 |
| The effect of endometrial thickness on in vitro fertilization (IVF)-embryo transfer/intracytoplasmic sperm injection (ICSI) outcome | 28.5 | 0 | 3 |
| Immunomodulatory treatment with intravenous immunoglobulin and prednisone in patients with recurrent miscarriage and implantation failure after in vitro fertilization/intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| An online survey of specialists’ opinion on first line management options for unexplained subfertility | 28.5 | 0 | 3 |
| Comparing intracytoplasmic sperm injection and in vitro fertilization in patients with single oocyte retrieval | 28.5 | 0 | 3 |
| Improved fertilization and embryo development resulting in birth of live piglets after intracytoplasmic sperm injection and in vitro culture in a cysteine-supplemented medium | 28.5 | 0 | 3 |
| Influence of in vitro oxygen concentrations on preimplantation embryo development, gene expression and production of Hanwoo calves following embryo transfer | 28.5 | 0 | 3 |
| 2006 Guidelines for Gamete and Embryo Donation | 28.5 | 0 | 3 |
| Use of the egg-share model to investigate the paternal influence on fertilization and embryo development after in vitro fertilization and intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Attitudes toward embryo donation among staff at in vitro fertilization clinics | 28.5 | 0 | 3 |
| Increasing sperm concentration to adjust for subnormal sperm morphology did not adversely affect implantation after embryo transfer | 28.5 | 0 | 3 |
| In vitro fertilization with intracytoplasmic sperm injection is an effective therapy for male factor infertility related to subnormal hypo-osmotic swelling test scores. | 28.5 | 0 | 3 |
| Intracytoplasmic sperm injection increased fertilization and good-quality embryo formation in patients with non-male factor indications for in vitro fertilization: a prospective randomized study | 28.5 | 0 | 3 |
| Perinatal outcomes of intrauterine insemination/clomiphene pregnancies represent an intermediate risk group compared with in vitro fertilisation/intracytoplasmic sperm injection and naturally conceived pregnancies | 28.5 | 0 | 3 |
| Factors affecting the success of human blastocyst development and pregnancy following in vitro fertilization and embryo transfer | 28.5 | 0 | 3 |
| Testicular sperm extraction and intracytoplasmic sperm injection: a chance of fertility in nonobstructive azoospermia | 28.5 | 0 | 3 |
| The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer | 28.5 | 0 | 3 |
| Leptin and nonessential amino acids enhance porcine preimplantation embryo development in vitro by intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Perforated appendicitis following transvaginal oocyte retrieval for in-vitro fertilization and embryo transfer | 28.5 | 0 | 3 |
| Changes induced in serum protein profiles by ovarian stimulation during in-vitro fertilization--embryo transfer treatment: a comparison between conception and non-conception cycles | 28.5 | 0 | 3 |
| Further observations on serial serum immunoreactive inhibin levels in the luteal phase and early gestation after ovarian stimulation for in vitro fertilization and embryo transfer | 28.5 | 0 | 3 |
| Comparison of four different ovarian stimulation protocols in an in vitro fertilisation & embryo transfer programme | 28.5 | 0 | 3 |
| Epididymal sperm aspiration in conjunction with in-vitro fertilization and embryo transfer in cases of obstructive azoospermia | 28.5 | 0 | 3 |
| Morphologic abnormalities in 2-year-old children born after in vitro fertilization/intracytoplasmic sperm injection with preimplantation genetic screening: follow-up of a randomized controlled trial | 28.5 | 0 | 3 |
| Minimal residual disease of leukemia and the quality of cryopreserved human ovarian tissue in vitro | 28.5 | 0 | 3 |
| Report of results obtained in 2,934 women using donor sperm: donor insemination versus in vitro fertilization according to indication | 28.5 | 0 | 3 |
| Multinucleation of a sibling blastomere on day 2 suggests unsuitability for embryo transfer in IVF–preimplantation genetic screening cycles | 28.5 | 0 | 3 |
| Comparison of in vitro fertilization/intracytoplasmic sperm injection outcomes in male factor infertility patients with and without spinal cord injuries | 28.5 | 0 | 3 |
| Anti-Müllerian hormone as a possible predictor of fecundability in subfertile women over 38 years: a retrospective cohort study | 28.5 | 0 | 3 |
| Results of donor insemination related to specific male infertility and unsuspected female infertility | 28.5 | 0 | 3 |
| Annual report of Reproductive Endocrinology Committee, Japan Society of Obstetrics and Gynecology, 2013 | 28.5 | 0 | 3 |
| Clinical experience with an ovarian stimulation protocol for intrauterine insemination adopting a gonadotropin releasing hormone antagonist at low dose. | 28.5 | 0 | 3 |
| Does sperm morphology affect the outcome of intrauterine insemination in patients with normal sperm concentration and motility? | 28.5 | 0 | 3 |
| Genetic screening in Italian infertile couples undergoing intrauterine insemination and in vitro fertilization techniques: a multicentric study | 28.5 | 0 | 3 |
| Testicular sperm extraction and intracytoplasmic sperm injection: A simplified method for treatment of obstructive azoospermia | 28.5 | 0 | 3 |
| Sperm retrieval and intracytoplasmic sperm injection in men with nonobstructive azoospermia, and treated and untreated varicocele | 28.5 | 0 | 3 |
| Choosing the right stimulation protocol for in vitro fertilization-embryo transfer in poor, normal, and hyper-responders | 28.5 | 0 | 3 |
| A prospective randomized noninferiority study comparing recombinant FSH and highly purified menotropin in intrauterine insemination cycles in couples with unexplained infertility and/or mild-moderate male factor. | 28.5 | 0 | 3 |
| Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An ana | 28.5 | 0 | 3 |
| Subnormal sperm parameters in conventional semen analysis are associated with discrepancies between fertilization and pregnancy rates in in-vitro fertilization and embryo transfer | 28.5 | 0 | 3 |
| Oxidative stress on mouse embryo development in vitro | 28.5 | 0 | 3 |
| Factors influencing the success rate of human embryo freezing in an in vitro fertilization and embryo transfer program. | 28.5 | 0 | 3 |
| Luteal-phase ovarian stimulation increases the number of mature oocytes in older women with severe diminished ovarian reserve | 28.5 | 0 | 3 |
| Effect of two insecticides and two herbicides on the porcine sperm motility patterns using computer-assisted semen analysis (CASA) in vitro | 28.5 | 0 | 3 |
| Strategies of sperm collection from men with temporary penile erectile dysfunction on the day of oocyte retrieval and the outcomes of IVF-ET | 28.5 | 0 | 3 |
| Re: Predictive Value of Sperm Morphology and Progressively Motile Sperm Count for Pregnancy Outcomes in Intrauterine Insemination | 28.5 | 0 | 3 |
| Preferences for intracytoplasmic sperm injection versus donor insemination in severe male factor infertility: a preliminary report | 28.5 | 0 | 3 |
| Microdissection TESE is superior to conventional TESE in patients with nonobstructive azoospermia caused by Y chromosome microdeletions | 28.5 | 0 | 3 |
| Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old? | 28.5 | 0 | 3 |
| Relationship of sperm morphology with the outcomes of in vitro fertilization and embryo transfer | 28.5 | 0 | 3 |
| Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer | 28.5 | 0 | 3 |
| The relationship of sperm DNA fragmentation index with the outcomes ofin-vitrofertilisation-embryo transfer and intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Anti-Müllerian hormone levels after laparoscopic cystectomy for endometriomas as a possible predictor for pregnancy in infertility treatments | 28.5 | 0 | 3 |
| Characterization of Nuclease Activity in Human Seminal Plasma and its Relationship to Semen Parameters, Sperm DNA Fragmentation and Male Infertility. | 28.5 | 0 | 3 |
| DNA fragmentation in brighter sperm predicts male fertility independently from age and semen parameters | 28.5 | 0 | 3 |
| Assessment of sperm quality parameters of six bulls showing different abilities to promote embryo development in vitro | 28.5 | 0 | 3 |
| HYPERBARIC OXYGEN THERAPY IN THE TREATMENT OF MALE INFERTILITY ASSOCIATED WITH INCREASED SPERM DNA FRAGMENTATION AND REACTIVE OXYGEN SPECIES IN SEMEN | 28.5 | 0 | 3 |
| Early pregnancy loss is significantly higher after day 3 single embryo transfer than after day 5 single blastocyst transfer in GnRH antagonist stimulated IVF cycles | 28.5 | 0 | 3 |
| Effects of cystectomy for ovary benign cyst on ovarian reserve and pregnancy outcome of in vitro fertilization-embryo transfer cycle | 28.5 | 0 | 3 |
| Oxidative stress and semen parameters in the serum and seminal plasma of infertile men with chronic viral hepatitis | 28.5 | 0 | 3 |
| Recommendations for practices utilizing gestational carriers: a committee opinion | 28.5 | 0 | 3 |
| Re: Effect of Semen Quality on Human Sex Ratio in In Vitro Fertilization and Intracytoplasmic Sperm Injection: An Analysis of 27,158 Singleton Infants Born after Fresh Single-Embryo Transfer | 28.5 | 0 | 3 |
| In-vitro fertilization, embryo transfer, and embryo freezing | 28.5 | 0 | 3 |
| Successful in Vitro Fertilization and Embryo Transfer after Transplantation of Cryopreserved Ovarian Tissue: Report of the First Korean Case. | 28.5 | 0 | 3 |
| Association Between Progesterone Elevation on the Day of Human Chronic Gonadotropin Trigger and Pregnancy Outcomes After Fresh Embryo Transfer in In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles. | 28.5 | 0 | 3 |
| Retrospective Study to Compare Frozen-Thawed Embryo Transfer with Fresh Embryo Transfer on Pregnancy Outcome Following Intracytoplasmic Sperm Injection for Male Infertility. | 28.5 | 0 | 3 |
| Effect of oocyte transportation time on the clinical results of transport in vitro fertilization/intracytoplasmic sperm injection-embryo transfer | 28.5 | 0 | 3 |
| Testicular sperm extraction with intracytoplasmic sperm injection for male infertility | 28.5 | 0 | 3 |
| Chromosomal abnormalities in infertile men with azoospermia and severe oligozoospermia in Qatar and their association with sperm retrieval intracytoplasmic sperm injection outcomes | 28.5 | 0 | 3 |
| Sperm DNA damage measured by the alkaline Comet assay as an independent predictor of male infertility and in vitro fertilization success | 28.5 | 0 | 3 |
| Systematic review of antioxidant types and doses in male infertility: Benefits on semen parameters, advanced sperm function, assisted reproduction and live-birth rate | 28.5 | 0 | 3 |
| Trust women to choose: a response to John a Robertson's 'Egg freezing and Egg banking: empowerment and alienation in assisted reproduction'. | 28.5 | 0 | 3 |
| Association of the peripheral blood levels of circulating microRNAs with both recurrent miscarriage and the outcomes of embryo transfer in an in vitro fertilization process | 28.5 | 0 | 3 |
| Testicular histopathology, semen analysis and FSH, predictive value of sperm retrieval: supportive counseling in case of reoperation after testicular sperm extraction (TESE). | 28.5 | 0 | 3 |
| Luteal Phase Ovarian Stimulation May Improve Oocyte Retrieval and Oocyte Quality in Poor Ovarian Responders Undergoing In Vitro Fertilization: Preliminary Results from a Single-Center Prospective Pilot Study | 28.5 | 0 | 3 |
| Cumulative live birth rates in more than 3,000 patients with poor ovarian response: a 15-year survey of final in vitro fertilization outcome | 28.5 | 0 | 3 |
| Update on fertility preservation from the Barcelona International Society for Fertility Preservation–ESHRE–ASRM 2015 expert meeting: indications, results and future perspectives†‡ | 28.5 | 0 | 3 |
| Effect of Trolox on sperm quality in normozospermia and oligozospermia during cryopreservation | 28.5 | 0 | 3 |
| Effects of cryopreservation on sperm quality, nuclear DNA integrity, in vitro fertilization, and in vitro embryo development in the mouse | 28.5 | 0 | 3 |
| Multicenter evaluation of the Access AMH antimüllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation | 28.5 | 0 | 3 |
| In-vitro fertilization (IVF), embryo transfer (ET) and assisted reproduction in the State of Israel | 28.5 | 0 | 3 |
| The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling | 28.5 | 0 | 3 |
| How much does the uterus matter? Perinatal outcomes are improved when donor oocyte embryos are transferred to gestational carriers compared to intended parent recipients | 28.5 | 0 | 3 |
| Impact of male partner characteristics and semen parameters on in vitro fertilization and obstetric outcomes in a frozen oocyte donor model | 28.5 | 0 | 3 |
| Egg donation model: an excellent way to isolate and analyze the impact of the male partner on assisted reproductive technology outcome | 28.5 | 0 | 3 |
| Sperm DNA fragmentation index as a promising predictive tool for male infertility diagnosis and treatment management - meta-analyses | 28.5 | 0 | 3 |
| Meta-analysis of the association between chromosomal polymorphisms and outcomes of embryo transfer following in vitro fertilization and/or intracytoplasmic sperm injection | 28.5 | 0 | 3 |
| Sharing of human leukocyte antigens in couples with unexplained infertility affects the success of in vitro fertilization and tubal embryo transfer | 28.5 | 0 | 3 |
| High endogenous melatonin concentrations enhance sperm quality and short-term in vitro exposure to melatonin improves aspects of sperm motility | 28.5 | 0 | 3 |
| Semen parameters on the day of oocyte retrieval predict low fertilization during conventional insemination IVF cycles | 28.5 | 0 | 3 |
| Re: Men with Severe Oligospermia Appear to Benefit from Varicocele Repair: A Cost-Effectiveness Analysis of Assisted Reproductive Technology | 28.5 | 0 | 3 |
| Re: Fertility Preservation for Men with Testicular Cancer: Is Sperm Cryopreservation Cost Effective in the Era of Assisted Reproductive Technology? | 28.5 | 0 | 3 |
| Ovarian Reserve And Assisted Reproductive Technique Outcomes After Laparoscopic Proximal Tubal Occlusion Or Salpingectomy In Women With Hydrosalpinx Undergoing In-Vitro Fertilization: A Randomized Controlled Trial | 28.5 | 0 | 3 |
| Observational retrospective study of US national utilisation patterns and live birth rates for various ovarian stimulation protocols for in vitro fertilisation | 28.5 | 0 | 3 |
| THE OPTIMAL INTERVAL OF TIME FROM OPERATIVE HYSTEROSCOPY TO EMBRYO TRANSFER IN AN IVF CYCLE | 28.5 | 0 | 3 |
| Fertility preservation with random-start controlled ovarian stimulation and embryo cryopreservation for early pregnancy-associated breast cancer | 28.5 | 0 | 3 |
| Shared-risk or refund programs in assisted reproduction. The Ethics Committee of the American Society for Reproductive Medicine | 28.5 | 0 | 3 |
| The use of assisted reproductive technology before male factor infertility evaluation | 28.5 | 0 | 3 |
| Chromosomal abnormalities and embryo development in recurrent miscarriage couples | 28.5 | 0 | 3 |
| Preimplantation genetic screening as an alternative to prenatal testing for Down syndrome: preferences of women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment | 28.5 | 0 | 3 |
| Unexplained Infertility and the Possibilities of Management with In Vitro Fertilization and Embyro Transfer | 28.5 | 0 | 3 |
| The relationship of tubal blockage, infertility of unknown cause, suspected male infertility, and endometriosis to success of in vitro fertilization and embryo transfer | 28.5 | 0 | 3 |
| 229 SHORT-TERM EXPOSURE OF MATURE OOCYTES TO A NITRIC OXIDE DONOR FOR INDUCING OXIDATIVE STRESS RESISTANCE ON IN VITRO-PRODUCED BOVINE EMBRYOS | 28.5 | 0 | 3 |
| La cryopréservation ovocytaire va-t-elle relancer l’intérêt du prélèvement chirurgical de spermatozoïdes synchrone du recueil ovocytaire en cas d’azoospermie non obstructive ? | 28.5 | 0 | 3 |
| Azoospermie non obstructive : intérêt du prélèvement testiculaire synchrone du recueil ovocytaire | 28.5 | 0 | 3 |
| Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman’s age and markers of ovarian reserve | 28.5 | 0 | 3 |
| Interest of Clomiphene Citrate in Patients With Non-obstructive Azoospermia on the Quantity of Sperm Cells | 28.5 | 0 | 3 |
| Anti-Müllerian Hormone is Not Predictive of Pregnancy in Donor Insemination Cycles in Non-infertile Women | 28.5 | 0 | 3 |
| Individual Versus Standard Follicle Stimulating Hormone Dose for Controlled Ovarian Stimulation and Insemination | 28.5 | 0 | 3 |
| Prevalence of abnormal semen analysis and levels of adherence with fertility preservation in men undergoing therapy for newly diagnosed cancer: A retrospective study in 2906 patients | 28.5 | 0 | 3 |
| Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVF | 28.5 | 0 | 3 |
| Can anti-Mullerian hormone (AMH) predict the outcome of intrauterine insemination with controlled ovarian stimulation? | 28.5 | 0 | 3 |
| Split Cohort Trial Comparing IVF Outcomes After the Use of Testicular vs. Ejaculated Sperm for ICSI | 28.5 | 0 | 3 |
| GnRH Agonist at Embryo Transfer: IVF Outcomes | 28.5 | 0 | 3 |
| Sperm Oxidative Stress and Pregnancy Success During IUI and IVF | 28.5 | 0 | 3 |
| Ultrasound Study by Texturization as a Predictor of Pregnancy in Oocyte Donation Programs | 28.5 | 0 | 3 |
| Effect of Intrauterine Injection of Hcg Before ET on Clinical Outcomes in IVF/ICSI Cycles | 28.5 | 0 | 3 |
| Preimplantation Genetic Screening (PGS) in Advanced Female Age and Male Severe Factor | 28.5 | 0 | 3 |
| Effect of Oocyte Vitrification on Fertilization Rate, Embryo Quality and Development | 28.5 | 0 | 3 |
| Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation | 28.5 | 0 | 3 |
| Metformin in High Responder Polycystic Ovary Syndrome (PCOS) Patients Undergoing IVF Cycles | 28.5 | 0 | 3 |
| Preimplantation genetic screening (PGS): a tool to increase live birth rates in couples with unexplained recurrent miscarriage? | 28.5 | 0 | 3 |
| Interest of Automated Oocyte Freezing | 28.5 | 0 | 3 |
| In Vitro Effects of Procyanidine on Semen Parameter and DFI | 28.5 | 0 | 3 |
| ICSI Versus Conventional IVF in Non-male Factor Couples | 28.5 | 0 | 3 |
| Does the Embryo Transfer Technique Affect the Success of in Vitro Fertilization? | 28.5 | 0 | 3 |
| Ovarian Stimulation: Inositol and Melatonin | 28.5 | 0 | 3 |
| EXpression PRofile Endometrium Samples Study | 28.5 | 0 | 3 |
| An Open Label, Canadian Phase IIIb Study With Ovidrel in Ovulation Induction (OI) and Assisted Reproductive Technique (ART) | 28.5 | 0 | 3 |
| Aneuploidy Rate and Stimulation Protocol: Recombinant Follicle Stimulating Hormone (FSH) Versus Human FSH | 28.5 | 0 | 3 |
| Clinical Measures of Ovarian Reserve in Predicting IVF Success | 28.5 | 0 | 3 |
| Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity | 28.5 | 0 | 3 |
| Effects of paternal age on human embryo development in in vitro fertilization with preimplantation genetic screening | 28.5 | 0 | 3 |
| A Comparison Between Two Assays for Measuring Seminal Oxidative Stress and their Relationship with Sperm DNA Fragmentation and Semen Parameters | 28.5 | 0 | 3 |
| A Novel Predictive Model to Estimate the Number of Mature Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing Fertilization/Intracytoplasmic Sperm Injection: The ART Calculator | 28.5 | 0 | 3 |
| What advice should we give our patients to preserve their fertility and avoid needing oocyte donation in the future? - A Social Fertility Preservation program | 28.5 | 0 | 3 |
| Oocyte cryopreservation for future fertility: comparison of ovarian response between cancer and non-cancer patients | 28.5 | 0 | 3 |
| Effect of Sperm DNA Fragmentation on Embryo Quality in Normal Responder Women in In Vitro Fertilization and Intracytoplasmic Sperm Injection | 28.5 | 0 | 3 |
| A cost-effectiveness analysis of preimplantation genetic testing for aneuploidy (PGT-A) for up to three complete assisted reproductive technology cycles in women of advanced maternal age | 28.5 | 0 | 3 |
| Elective single embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics | 28.5 | 0 | 3 |
| Live birth and multiple birth rates in US in vitro fertilization treatment using donor oocytes: a comparison of single-embryo transfer and double-embryo transfer | 28.5 | 0 | 3 |
| Comparison of the Number of Oocytes Obtained Between Chinese and Caucasian Women in IVF Treatment | 28.5 | 0 | 3 |
| Letrozole in Stimulated IVF Cycles | 28.5 | 0 | 3 |
| Correlation between Ovarian Reserve and Incidence of Ectopic Pregnancy after Fertilization and Embryo Transfer | 28.5 | 0 | 3 |
| Delayed Embryo Transfer in Poor Responders | 28.5 | 0 | 3 |
| Biomarkers of Ovarian Reserve and Correlation With IVF Treatments | 28.5 | 0 | 3 |
| Correlating In Vitro Fertilization Outcomes After Euploid Blastocyst Transfer With Sperm DNA Fragmentation | 28.5 | 0 | 3 |
| Clomiphene Citrate in Combination With Gonadotropins for Ovarian Stimulation in Women With Poor Ovarian Response. | 28.5 | 0 | 3 |
| Prognostic Value of Progesterone on Oocyte Retrieval Day for In Vitro Fertilization Outcome | 28.5 | 0 | 3 |
| Anti-oxidative Influence From Pomegranate Tablets on Male Sperm Quality in Couples Undergo Infertility Treatments Due to Male Infertility. | 28.5 | 0 | 3 |
| Intralipid Therapy for Women 35-40 Years With Positive Natural Killer Cells Undergoing Intracytoplasmic Sperm Injection (ICSI) | 28.5 | 0 | 3 |
| Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles | 28.5 | 0 | 3 |
| Laparoscopic Ovarian Cystectomy of Endometrioma vs Deroofing and Ovarian Reserve | 28.5 | 0 | 3 |
| New York University | 26.9 | 3 | 0 |
| National Institute for Occupational Safety and Health | 26.9 | 3 | 0 |
| Q229883 | 26.9 | 3 | 0 |
| Clinical Genitourinary Cancer | 26.9 | 3 | 0 |
| United States National Institutes of Health | 26.9 | 3 | 0 |
| Cryptologia | 26.9 | 3 | 0 |
| Autophagy | 26.9 | 3 | 0 |
| National Geographic Traveler | 26.9 | 3 | 0 |
| Seminars in Cancer Biology | 26.9 | 3 | 0 |
| Communications in Soil Science and Plant Analysis | 26.9 | 3 | 0 |
| Animal Biotechnology | 26.9 | 3 | 0 |
| Quantitative Infra Red Thermography Journal | 26.9 | 3 | 0 |
| Brain and Language | 26.9 | 3 | 0 |
| Cancer Biology and Therapy | 26.9 | 3 | 0 |
| American Mathematical Monthly | 26.9 | 3 | 0 |
| Quarterly Journal of Experimental Psychology | 26.9 | 3 | 0 |
| Journal of Applied Animal Research | 26.9 | 3 | 0 |
| Synthetic Communications | 26.9 | 3 | 0 |
| Imago Mundi | 26.9 | 3 | 0 |
| Journal of the American Statistical Association | 26.9 | 3 | 0 |
| Algebra Universalis | 26.9 | 3 | 0 |
| American Family Physician | 26.9 | 3 | 0 |
| American Journal of Orthodontics and Dentofacial Orthopedics | 26.9 | 3 | 0 |
| American Journal of Sexuality Education | 26.9 | 3 | 0 |
| JAMA Facial Plastic Surgery | 26.9 | 3 | 0 |
| Dance Chronicle | 26.9 | 3 | 0 |
| The University of Vermont Medical Center | 26.9 | 3 | 0 |
| Israel Journal of Foreign Affairs | 26.9 | 3 | 0 |
| JOM | 26.9 | 3 | 0 |
| Journal of Contemporary China | 26.9 | 3 | 0 |
| Journal of Library Administration | 26.9 | 3 | 0 |
| Labor History | 26.9 | 3 | 0 |
| Monoclonal Antibodies | 26.9 | 3 | 0 |
| Mediterranean Historical Review | 26.9 | 3 | 0 |
| Museum Management and Curatorship | 26.9 | 3 | 0 |
| Nordic Journal for Masculinity Studies | 26.9 | 3 | 0 |
| Parents | 26.9 | 3 | 0 |
| Psychological Reports | 26.9 | 3 | 0 |
| Quality Engineering | 26.9 | 3 | 0 |
| RNA Biology | 26.9 | 3 | 0 |
| Religion | 26.9 | 3 | 0 |
| Reproductive Health Matters | 26.9 | 3 | 0 |
| Social Movement Studies | 26.9 | 3 | 0 |
| The Professional Geographer | 26.9 | 3 | 0 |
| Urban Geography | 26.9 | 3 | 0 |
| The AAPS Journal | 26.9 | 3 | 0 |
| The American Statistician | 26.9 | 3 | 0 |
| Stochastics | 26.9 | 3 | 0 |
| Transport Theory and Statistical Physics | 26.9 | 3 | 0 |
| Aequationes Mathematicae | 26.9 | 3 | 0 |
| Applied Mathematics and Computation | 26.9 | 3 | 0 |
| International Journal of Biodiversity Science, Ecosystem Services & Management | 26.9 | 3 | 0 |
| Journal of Carbohydrate Chemistry | 26.9 | 3 | 0 |
| World Immunization Week | 26.9 | 3 | 0 |
| Journal of Essential Oil Research | 26.9 | 3 | 0 |
| Porn Studies | 26.9 | 3 | 0 |
| Tissue Barriers | 26.9 | 3 | 0 |
| Small GTPases (journal) | 26.9 | 3 | 0 |
| Oxford Development Studies | 26.9 | 3 | 0 |
| Gastrointestinal Endoscopy | 26.9 | 3 | 0 |
| Food Additives And Contaminants Part B: Surveillance Communications | 26.9 | 3 | 0 |
| Journal of Youth Studies | 26.9 | 3 | 0 |
| Spatial Economic Analysis | 26.9 | 3 | 0 |
| American Journalism | 26.9 | 3 | 0 |
| Analytical Letters | 26.9 | 3 | 0 |
| Arboricultural Journal | 26.9 | 3 | 0 |
| Journal of Applied Statistics | 26.9 | 3 | 0 |
| Communications in Statistics: Simulation and Computation | 26.9 | 3 | 0 |
| Health Care for Women International | 26.9 | 3 | 0 |
| British Journal of Biomedical Science | 26.9 | 3 | 0 |
| Studies on Neotropical Fauna and Environment | 26.9 | 3 | 0 |
| Scandinavian Journal of History | 26.9 | 3 | 0 |
| International Review of Psychiatry | 26.9 | 3 | 0 |
| Advances in Virus Research | 26.9 | 3 | 0 |
| Life Writing | 26.9 | 3 | 0 |
| History of Photography | 26.9 | 3 | 0 |
| Epigenetics | 26.9 | 3 | 0 |
| Best Practice and Research: Clinical Gastroenterology | 26.9 | 3 | 0 |
| Canadian Slavonic Papers | 26.9 | 3 | 0 |
| Hum Vaccin | 26.9 | 3 | 0 |
| AKCE International Journal of Graphs and Combinatorics | 26.9 | 3 | 0 |
| Journal of Iberian and Latin American Studies | 26.9 | 3 | 0 |
| The Social Science Journal | 26.9 | 3 | 0 |
| Journal of Risk Research | 26.9 | 3 | 0 |
| Journal of Immunoassay and Immunochemistry | 26.9 | 3 | 0 |
| Journal of Architectural Conservation | 26.9 | 3 | 0 |
| Language and Cognitive Processes | 26.9 | 3 | 0 |
| New Zealand Entomologist | 26.9 | 3 | 0 |
| Baltic Journal of Economics | 26.9 | 3 | 0 |
| Sport Management Review | 26.9 | 3 | 0 |
| Australian Forestry | 26.9 | 3 | 0 |
| Romance Quarterly | 26.9 | 3 | 0 |
| Citizenship Studies | 26.9 | 3 | 0 |
| Journal of Information Technology Case and Application Research | 26.9 | 3 | 0 |
| Physical Geography | 26.9 | 3 | 0 |
| Psychiatry | 26.9 | 3 | 0 |
| Intelligence and National Security | 26.9 | 3 | 0 |
| South African Historical Journal | 26.9 | 3 | 0 |
| International Journal of Sport and Exercise Psychology | 26.9 | 3 | 0 |
| Music Reference Services Quarterly | 26.9 | 3 | 0 |
| British Journal of Middle Eastern Studies | 26.9 | 3 | 0 |
| International Journal of Modelling and Simulation | 26.9 | 3 | 0 |
| Neural Development | 26.9 | 3 | 0 |
| Organogenesis | 26.9 | 3 | 0 |
| Social Dynamics | 26.9 | 3 | 0 |
| Global Public Health | 26.9 | 3 | 0 |
| Word and Image | 26.9 | 3 | 0 |
| The Review of Black Political Economy | 26.9 | 3 | 0 |
| Channels | 26.9 | 3 | 0 |
| Advances in Parasitology | 26.9 | 3 | 0 |
| Youth Theatre Journal | 26.9 | 3 | 0 |
| Journal of Biopharmaceutical Statistics | 26.9 | 3 | 0 |
| Visual Resources | 26.9 | 3 | 0 |
| Journal of Divorce and Remarriage | 26.9 | 3 | 0 |
| Women's History Review | 26.9 | 3 | 0 |
| Cold War History | 26.9 | 3 | 0 |
| Visual Culture in Britain | 26.9 | 3 | 0 |
| Parenting: Science and Practice | 26.9 | 3 | 0 |
| South Asian History and Culture | 26.9 | 3 | 0 |
| Journal of Graphic Novels and Comics | 26.9 | 3 | 0 |
| Journal of Electronic Resources in Medical Libraries | 26.9 | 3 | 0 |
| Journal of Family Psychotherapy | 26.9 | 3 | 0 |
| Cell Adhesion and Migration | 26.9 | 3 | 0 |
| Journal of Social Work Practice in the Addictions | 26.9 | 3 | 0 |
| Mycology | 26.9 | 3 | 0 |
| Annals of GIS | 26.9 | 3 | 0 |
| Medical Reference Services Quarterly | 26.9 | 3 | 0 |
| OncoImmunology | 26.9 | 3 | 0 |
| Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | 26.9 | 3 | 0 |
| Applied Biosafety | 26.9 | 3 | 0 |
| Cellular logistics | 26.9 | 3 | 0 |
| Biomatter | 26.9 | 3 | 0 |
| Spermatogenesis | 26.9 | 3 | 0 |
| JAK-STAT | 26.9 | 3 | 0 |
| Bioengineered | 26.9 | 3 | 0 |
| Libyan journal of medicine | 26.9 | 3 | 0 |
| Vital and health statistics. Series 21, Data on natality, marriage, and divorce | 26.9 | 3 | 0 |
| Vital and health statistics. Series 5, Comparative international vital and health statistics reports | 26.9 | 3 | 0 |
| Harvard men's health watch | 26.9 | 3 | 0 |
| Harvard women's health watch | 26.9 | 3 | 0 |
| Industrial biotechnology (New Rochelle, N.Y.) | 26.9 | 3 | 0 |
| Applied neuropsychology. Adult | 26.9 | 3 | 0 |
| Advances in eating disorders (Abingdon, England ) | 26.9 | 3 | 0 |
| Applied neuropsychology. Child | 26.9 | 3 | 0 |
| Computer methods in biomechanics and biomedical engineering. Imaging & visualization | 26.9 | 3 | 0 |
| Rare diseases (Austin, Tex.) | 26.9 | 3 | 0 |
| Journal of sport psychology in action | 26.9 | 3 | 0 |
| Migration and development | 26.9 | 3 | 0 |
| Perspectives on political science | 26.9 | 3 | 0 |
| EURO Journal on Computational Optimization | 26.9 | 3 | 0 |
| Chronic Diseases and Translational Medicine | 26.9 | 3 | 0 |
| World Journal of Otorhinolaryngology-Head and Neck Surgery | 26.9 | 3 | 0 |
| Church, Communication and Culture | 26.9 | 3 | 0 |
| Monograph of the Palaeontographical Society | 26.9 | 3 | 0 |
| Journal of Computational and Theoretical Transport | 26.9 | 3 | 0 |
| Journal of Global Scholars of Marketing Science | 26.9 | 3 | 0 |
| Russian Journal of Communication | 26.9 | 3 | 0 |
| Global Discourse | 26.9 | 3 | 0 |
| Journal of Responsible Innovation | 26.9 | 3 | 0 |
| Cricket and Community in England: 1800 to the Present Day | 26.9 | 3 | 0 |
| Towards World Heritage: International Origins of the Preservation Movement, 1870–1930 | 26.9 | 3 | 0 |
| Clinical Trials Cannot Substitute for Health System Strengthening Initiatives or Specifically Designed Health Policy and Systems Research | 26.9 | 3 | 0 |
| Inspired Translation: Synthesizing Qualitative Research and Boot Camp Translation to Achieve Meaningful Community Engagement | 26.9 | 3 | 0 |
| Scriptless Connection of Sensor Data Processing Components in Network Middleware for Home Environment | 26.9 | 3 | 0 |
| Development of an In Situ Thermal Desorption Gas Chromatography Instrument for Quantifying Atmospheric Semi-Volatile Organic Compounds | 26.9 | 3 | 0 |
| CyberEx Internet-Based Group Exercise for Rural Older Adults: A Pilot Study | 26.9 | 3 | 0 |
| Feasibility and impact of implementing motivational enhancement therapy–cognitive behavioral therapy as a substance use treatment intervention in school-based settings | 26.9 | 3 | 0 |
| Exploring a Mindfulness Meditation Program on the Mental Health of Upper Primary Children: A Pilot Study | 26.9 | 3 | 0 |
| Unpacking Interdisciplinary Collaboration in Expanded School Mental Health: A Conceptual Model for Developing the Evidence Base | 26.9 | 3 | 0 |
| Functional Fitness Testing of Older Adults: An Intergenerational Service Learning Experience | 26.9 | 3 | 0 |
| Mental Health Issues of Older Women: A Comprehensive Review for Health Care Professionals, edited by Victor J. Malatesta | 26.9 | 3 | 0 |
| Single Set Strength Training Increases Strength, Endurance and Functional Fitness in Community Living Older Adults | 26.9 | 3 | 0 |
| “To Form a More Perfect Union”: How a University and a Public School District Collaborated to Create a Field-Based Masters Degree Program in Elementary Education | 26.9 | 3 | 0 |
| African Journalism Studies | 26.9 | 3 | 0 |
| Peacebuilding | 26.9 | 3 | 0 |
| Journal of Trust Research | 26.9 | 3 | 0 |
| Méthod(e)s African Review of Social Sciences Methodology | 26.9 | 3 | 0 |
| Area Development and Policy | 26.9 | 3 | 0 |
| Asia Pacific Translation and Intercultural Studies | 26.9 | 3 | 0 |
| Canadian Art Therapy Association Journal | 26.9 | 3 | 0 |
| Cities & Health | 26.9 | 3 | 0 |
| Comedy Studies | 26.9 | 3 | 0 |
| Counseling Outcome Research and Evaluation | 26.9 | 3 | 0 |
| Critical Studies on Security | 26.9 | 3 | 0 |
| Health Systems & Reform | 26.9 | 3 | 0 |
| Oncology Issues | 26.9 | 3 | 0 |
| Papers in Applied Geography | 26.9 | 3 | 0 |
| Studies in Eastern European Cinema | 26.9 | 3 | 0 |